WO2009074465A2 - Conditionneurs capillaires contenant des composés béhényle cationiques et des silicones sélectionnées et/ou des huiles cosmétiques - Google Patents

Conditionneurs capillaires contenant des composés béhényle cationiques et des silicones sélectionnées et/ou des huiles cosmétiques Download PDF

Info

Publication number
WO2009074465A2
WO2009074465A2 PCT/EP2008/066424 EP2008066424W WO2009074465A2 WO 2009074465 A2 WO2009074465 A2 WO 2009074465A2 EP 2008066424 W EP2008066424 W EP 2008066424W WO 2009074465 A2 WO2009074465 A2 WO 2009074465A2
Authority
WO
WIPO (PCT)
Prior art keywords
group
acid
alkyl
hair
cationic
Prior art date
Application number
PCT/EP2008/066424
Other languages
German (de)
English (en)
Other versions
WO2009074465A3 (fr
Inventor
Marcus Krueger
Dieter Goddinger
Original Assignee
Henkel Ag & Co. Kgaa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel Ag & Co. Kgaa filed Critical Henkel Ag & Co. Kgaa
Publication of WO2009074465A2 publication Critical patent/WO2009074465A2/fr
Publication of WO2009074465A3 publication Critical patent/WO2009074465A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A61K8/416—Quaternary ammonium compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/58—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
    • A61K8/585—Organosilicon compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89—Polysiloxanes
    • A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89—Polysiloxanes
    • A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • A61K8/892—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone modified by a hydroxy group, e.g. dimethiconol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89—Polysiloxanes
    • A61K8/896—Polysiloxanes containing atoms other than silicon, carbon, oxygen and hydrogen, e.g. dimethicone copolyol phosphate
    • A61K8/898—Polysiloxanes containing atoms other than silicon, carbon, oxygen and hydrogen, e.g. dimethicone copolyol phosphate containing nitrogen, e.g. amodimethicone, trimethyl silyl amodimethicone or dimethicone propyl PG-betaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/12—Preparations containing hair conditioners
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/04—Preparations for permanent waving or straightening the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/08—Preparations for bleaching the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/10—Preparations for permanently dyeing the hair

Definitions

  • the invention relates to hair treatment compositions containing cationic behenyl compounds and selected silicones and / or cosmetic oils and the use of these agents for the treatment of skin and hair.
  • Quaternary ammonium compounds of the mono-, di- and / or trialkylammonium type have been known for a long time.
  • a disadvantage of these compounds is their lack of biodegradability. Therefore, cationic compounds containing at least one ester group, the so-called ester quats, have been developed. These, however, show a sensation of being unpleasantly dull in terms of the feel and feel of wet skin and hair as well as the touch and feel of the rewashed skin or hair, which is also perceived as "squeaky” audible.
  • an active ingredient combination of at least one derivative of the cationic behenyl compounds as shown in the formula I, and at least one silicone polymer selected from the group of dimethiconols and / or the group of amino-functional silicones and / or the group
  • the cyclomethicone and / or the group of dimethicones and / or the group of cosmetic oils achieves particularly advantageous results
  • a highly preferred combination of active ingredients further comprises at least one dimethicone and / or one cyclomethicone and at least one additional kosme table oil.
  • a first subject of the present invention is therefore a composition for the treatment of keratinic fibers, comprising a) at least one behenylate quaternary compound according to the formula I and b) at least one silicone polymer selected from the group of dimethiconols and / or the group of amino-functional silicones and / or the group of cyclomethiconols and / or the group of dimethicones and / or the group of cosmetic oils and / or mixtures thereof, wherein the weight ratio of imidazoline derivatives (a) to the respective silicone polymer or cosmetic oil or mixtures thereof (b) is 20: 1 to 1: 20 based on the respective active substance contents, and c) a cosmetic carrier.
  • compositions according to the invention contain an active ingredient combination of at least two constituents, the constituents a) and b) being used within a certain weight ratio to one another.
  • the weight ratio of derivatives a) of the formula I to one of the silicone derivatives and / or the cosmetic oil b) is from 20: 1 to 1:20, more preferably from 10: 1 to 1:10, particularly preferably from 5: 1 to 1 : 5 and especially 2.5: 1 to 1: 2.5.
  • the weight ratio between the silicone polymer and the cosmetic oil is at least 10: 1 to 1:10, preferably 5: 1 to 1: 5, more preferably 3: 1 to 1: 5, especially 1: 3 and most preferably 1: 2.
  • the silicone polymer is preferably selected from the group of dimethicones and / or the group of cyclomethicones. In this case, it may further be particularly preferred if both a dimethicone and a cyclomethicone are included together with the cosmetic oil.
  • Ingredients a) and b) are described in detail below.
  • Hair treatment compositions for the purposes of the present invention are, for example, hair dyes, bleaching agents, hair shampoos, hair conditioners, conditioning shampoos, hair sprays, hair rinses, hair treatments, hair wraps, hair tonics, perming solutions, hair dye shampoos, hair dyes, hair fixatives, hair dressings, hair styling preparations, hair lotions , Mousse, hair gels, hair waxes or combinations thereof.
  • Preferred agents according to the invention are therefore shampoos, conditioners or hair tonics.
  • combing is understood according to the invention both the combability of the wet fiber, as well as the combability of the dry fiber. As a measure of the combing used the combing work or the force used during the combing process of a fiber collective. The measurement parameters can be assessed by the skilled person or quantified by measuring devices.
  • the grip defines the tactility of a fiber collective, whereby the expert sensoryly senses and evaluates the parameters fullness and suppleness of the collective.
  • cosmetic creams, emulsions, gels or surfactant-containing foaming solutions for example shampoos, foam aerosols or other preparations which are particularly suitable for use on the hair
  • cosmetic carriers may in particular be aqueous or aqueous-alcoholic.
  • An aqueous cosmetic carrier contains at least 50% by weight of water.
  • aqueous-alcoholic cosmetic carriers include aqueous solutions containing from 3 to 70% by weight of a C 1 -C 6 -alkoHoI, in particular methanol, ethanol or propanol, isopropanol, butanol, isobutanol, tert-butanol, n -Pentanol, iso-pentanols, n-hexanol, iso-hexanols, glycol, glycerol, 1, 2-pentanediol, 1, 5-pentanediol, 1, 2-hexanediol or 1, 6-hexanediol to understand.
  • the compositions according to the invention may additionally contain further organic solvents, for example methoxybutanol, benzyl alcohol, ethyl diglycol or 1,2-propylene glycol. Preference is given to all water-soluble organic solvents.
  • compositions according to the invention comprise at least one quaternary behenyl compound, ie a compound which has a positively charged nitrogen atom and at least one behenyl radical on this nitrogen atom.
  • quaternary behenyl compound ie a compound which has a positively charged nitrogen atom and at least one behenyl radical on this nitrogen atom.
  • the formula I shown below shows the structure of these compounds.
  • the compounds of the formula I are present in the compositions according to the invention in amounts of from 0.01 to 20% by weight, preferably in amounts of from 0.05 to 10% by weight and very particularly preferably in amounts of from 0.1 to 7.5% by weight. % contain. The very best results are obtained with amounts of from 0.1 to 5% by weight, based in each case on the total composition of the particular agent.
  • the compositions according to the invention contain at least one silicone polymer selected from the group of dimethiconols and / or the group of amino-functional silicones and / or the group of dimethicones and / or the group of cyclomethicones and / or the group of cosmetic oils. These ingredients are described below.
  • the dimethicones according to the invention can be both linear and branched as well as cyclic or cyclic and branched.
  • Linear dimethicones can be represented by the following structural formula (Sil): (SiR 1 3 ) - O - (SiR 2 2 - O -) x - (SiR 1 3 ) (Sil)
  • Branched dimethicones can be represented by the structural formula (SiH) :
  • the radicals R 1 and R 2 are each independently hydrogen, a methyl radical, a C 2 to C 30 linear, saturated or unsaturated hydrocarbon radical, a phenyl radical and / or an aryl radical.
  • the groups represented by R 1 and R 2 include alkyl groups such as methyl, ethyl, propyl, isopropyl, butyl, isobutyl, pentyl, isopentyl, neopentyl, amyl, isoamyl, hexyl, isohexyl and the like; Alkenyl radicals such as vinyl, halovinyl, alkylvinyl, allyl, haloallyl, alkylallyl; Cycloalkyl radicals such as cyclobutyl, cyclopentyl, cyclohexyl and the like; Phenyl radicals, benzyl radicals, halohydrocarbon radicals such as 3-chloropropyl, 4-
  • R 1 examples include methylene, ethylene, propylene, hexamethylene, decamethylene, -CH 2 CH (CH 3 ) CH 2 -, phenylene, naphthylene, -CH 2 CH 2 SCH 2 CH 2 -, -CH 2 CH 2 OCH 2 - , -OCH 2 CH 2 -, -OCH 2 CH 2 CH 2 -, -CH 2 CH (CH 3 ) C (O) OCH 2 -, - (CH 2 ) 3 CC (O) OCH 2 CH 2 -, C 6 H 4 C 6 H 4 -, -C 6 H 4 CH 2 C 6 H 4 -; and - (CH 2 ) 3 C (O) SCH 2 CH 2 -.
  • R 1 and R 2 are methyl, phenyl and C 2 to C 22 alkyl radicals. Of the C2 to C22 alkyl radicals, lauryl, stearyl and behenyl radicals are particularly preferred.
  • the numbers x, y and z are integers and each run independently from 0 to 50,000.
  • the molecular weights of Dimethicone lie between 1,000 D and 10000000 D.
  • the viscosities are between 100 and 10,000,000 cPs measured at 25 0 C by means of a glass capillary viscometer according to Dow Corning Corporate Test Method CTM 0004 dated 20 July 1970. Preferred viscosities are 1000-5000000 cPs, most preferred viscosities are between 10,000 and 3,000,000 cps.
  • the most preferred range is between 50,000 and 2,000,000 cps. Most preferred are viscosities around the range of about 60,000 cps.
  • the word "about” defines a deviation from the stated value following the word “about” which is customary in the art for technically manufactured products.
  • the teaching according to the invention also encompasses the fact that the dimethicones may already be present as an emulsion If the dimethicones according to the invention are used as emulsion, then the droplet size of the emulsified particles is 0, 01 microns to 10,000 microns, preferably 0.01 to 100 microns, most preferably 0.01 to 20 microns and am most preferably 0.01 to 10 microns. The particle size is determined by the method of light scattering.
  • Particularly preferred cosmetic or dermatological preparations according to the invention are characterized in that they contain at least one silicone of the formula (Sil .2)
  • the dimethicones (Sil) are present in the compositions according to the invention in amounts of from 0.01 to 10% by weight, preferably from 0.01 to 8% by weight, more preferably from 0.1 to 7.5% by weight and in particular from 0.1 to 5 wt.% Based on the total composition.
  • Particularly preferred agents according to the invention contain one or more amino-functional silicones. Such silicones may e.g. by the formula (Si-2)
  • R is a hydrocarbon or a hydrocarbon radical having from 1 to about 6
  • Q is a polar radical of the general formula -R 1 HZ, wherein
  • R 1 is a divalent linking group bonded to hydrogen and the radical Z composed of carbon and hydrogen atoms, carbon, hydrogen and oxygen atoms or carbon, hydrogen and nitrogen atoms, and
  • Z is an organic, amino-functional group containing at least one amino-functional group; a assumes values in the range of about 0 to about 2, b takes values in the range of about 1 to about 3, a + b is less than or equal to 3, and c is a number in the range of about 1 to about 3, and x a number ranging from 1 to about 2,000, preferably from about 3 to about 50, and most preferably from about 3 to about 25; and y is a number ranging from about 20 to about 10,000, preferably from about 125 to about 10,000 and most preferred is from about 150 to about 1000, and M is a suitable silicone end group as known in the art, preferably trimethylsiloxy.
  • Non-limiting examples of the groups represented by R in formula (Si-2) include alkyl groups such as methyl, ethyl, propyl, isopropyl, isopropyl, butyl, isobutyl, amyl, isoamyl, hexyl, isohexyl and the like; Alkenyl radicals, such as vinyl, halovinyl, alkylvinyl, allyl, haloallyl, alkyl allyl; Cycloalkyl radicals such as cyclobutyl, cyclopentyl, cyclohexyl and the like; Phenyl radicals, benzyl radicals, halohydrocarbon radicals such as 3-chloropropyl, 4-bromobutyl, 3,3,3-trifluoropropyl, chlorocyclohexyl, bromophenyl, chlorophenyl and the like, and sulfur-containing radicals such as mercaptoethyl,
  • R 1 examples include methylene, ethylene, propylene, hexamethylene, decamethylene, - CH 2 CH (CH 3 ) CH 2 -, phenylene, naphthylene, -CH 2 CH 2 SCH 2 CH 2 -, -CH 2 CH 2 OCH 2 - , -OCH 2 CH 2 -, - OCH 2 CH 2 CH 2 -, -CH 2 CH (CH 3 ) C (O) OCH 2 -, - (CHz) 3 CC (O) OCH 2 CH 2 -, -C 6 H 4 C 6 H 4 -, -C 6 H 4 CH 2 C 6 H 4 -; and - (CH 2 ) 3 C (O) SCH 2 CH 2 -.
  • Z is according to formula (Si-2) an organic, amino-functional radical containing at least one functional amino group.
  • a possible formula for said Z is NH (CH 2 ) Z NH 2 , where z is an integer greater than or equal to 1.
  • Another possible formula for said Z is -NH (CH 2 ) Z (CH 2 ) ZZ NH, wherein both z and zz independently of one another are an integer greater than or equal to 1, this structure comprising diamino ring structures, such as piperazinyl.
  • Said Z is most preferably an -NHCH 2 CH 2 NH 2 radical.
  • Z is - N (CH 2 ) Z (CH 2 ) ZZ NX 2 or -NX 2 , wherein each X of X 2 is independently selected from the group consisting of hydrogen and alkyl groups of 1 to 12 carbon atoms, and zz is 0.
  • Q according to formula (Si-2) is most preferably a polar amino-functional radical of formula - CH 2 CH 2 CH 2 NH 2 CH 2 CH 2 NH 2 .
  • ⁇ assumes values in the range of 0 to 2
  • b takes values in the range of 2 to 3
  • a + b is less than or equal to 3
  • c is a number in the range of 1 to 3.
  • the molar ratio of the R a Q b SiO (4 a a b) / 2 units to the R 0 SiO (4 C) / 2 units in formula (Si-2) is in the range of about 1: From 2 to 1: 65, preferably from about 1: 5 to about 1:65, and most preferably from about 1:15 to about 1: 20. If one or more of the above formula (Si-2) silicones are used then the various variable substituents in the above formula may be different for the various silicone components present in the silicone blend.
  • Preferred cosmetic or dermatological preparations of the invention contain an amino-functional silicone of the formula (Si-3), R 'a G 3 _ a -Si (OSiG 2) n - (OSiG b R' 2 _ b) m -O-SiG 3 _ a - R 'a (Si-3), wherein means:
  • G is -H, a phenyl group, -OH, -O-CH 3 , -CH 3 , -O-CH 2 CH 3 , -CH 2 CH 3 , -O-CH 2 CH 2 CH 3 , -C / H 2 C / H2C / H3, -L) ⁇ C / H (C / H3) 2) ⁇ C / H (L / H3) 2 -O ⁇ J C / ⁇ 2C / H2C / ⁇ 2C / H3, -C / H2C / H2C / ⁇ 2C / ⁇ 3, -O-CH 2 CH (CH 3) 2, -CH 2 CH (CHs) 2, -0-CH (CH 3) CH 2 CH 3, -CH (CH 3) CH 2 CH 3, -OC (CH 3 ) 3 , -C (CH 3 ) 3 ; a is a number between O and 3, in particular O; b stands for a number between 0 and 1,
  • R ' is a monovalent radical selected from -QN (R ") - CH 2 -CH 2 -N (R") 2 -QN (R 11 J 2 -QN + (R ") 3 A- -QN + H (R ") 2 a" QN + H 2 (R ") a" -QN (R ”) - CH 2 -CH 2 -N + R" H 2 a ", each Q is a chemical bond, -CH 2 - , -CH 2 -CH 2 -, -CH 2 CH 2 CH 2 -, -C (CH 2 ) 2 -, -CH 2 CH 2 CH 2 CH 2 -, -CH 2 C (CH 3 ) 2 -, -CH (CH 3 ) CH 2 CH 2 -, R "is identical or different radicals from the group -H, -phenyl, -benzyl, -CH 2 -CH (CH 3 ) Ph, the Ci.
  • 20 -alkyl radicals preferably CH 3 , -CH 2 CH 3 , -CH 2 CH 2 CH 3 , -CH (CH 3 ) 2 , -CH 2 CH 2 CH 2 CH 3 , -CH 2 CH (CH 3 ) 2 , -CH (CH 3 ) CH 2 CH 3 , -C (CH 3 J 3 , and A represents an anion, which is preferably selected from chloride, bromide, iodide or methosulfate.
  • Cationic silicone oils such as the commercially available Dow Corning 929 emulsion (containing a hydroxylamino-modified silicone referred to as amodimethicone), DC 2-2078 (manufacturer Dow Corning, INCI name: Aminopropyl Phenyl Trimethicone), DC 5 are suitable according to the invention -7113 (manufacturer Dow Corning, INCI name: Silicone Quaternium 16), SM-2059 (manufacturer: General Electric), SLM-55067 (manufacturer: Wacker) and Abil ® quat 3270 and 3272 (manufacturer: Th Goldschmidt; diquaternary. Polydimethylsiloxanes, quaternium-80).
  • Particularly preferred agents according to the invention are characterized in that they contain at least one amino-functional silicone of the formula (Si 3-a)
  • silicones are referred to as trimethylsilylamodimethicones according to the INCI declaration and are available, for example, under the name Q2-7224 (manufacturer: Dow Corning, a stabilized trimethylsilylamodimethicone).
  • compositions according to the invention which contain at least one amino-functional silicone of the formula (Si-3b) R- [Si (CH 3) 2 -O] n1 [Si (R> O] m - [Si (CH 3) 2 -O] n2 SiMe 2 R (Si-3b),
  • R is -OH, (optionally ethoxylated and / or propoxylated) (C 1 to C 20 ) -
  • R ' is -OH, a (C 1 to C 20 ) alkoxy group or a -CH 3 group and m, n1 and n2 are numbers whose sum (m + n1 + n2) is between 1 and 2,000, preferably between 50 and Is 150, wherein the sum (n1 + n2) preferably takes values from 0 to 1999 and in particular from 49 to 149 and m preferably values from 1 to 2000, in particular from 1 to 10.
  • silicones are according to the INCI declaration as Amodimethicone, or as functionalized Amodimethicone, such as bis (C13-15 alkoxy) PG Amodimethicone (for example, as a commercial product: DC 8500 from Dow Corning available), trideceth-9 PG-amodimethicones (for example as a commercial product Silcare Silicone SEA available from Clariant).
  • amino-functional silicones preference is given to cosmetic or dermatological preparations according to the invention which contain an amino-functional silicone whose amine number is above 0.25 meq / g, preferably above 0.3 meq / g and in particular above 0.4 meq / g is.
  • the amine number stands for the milliequivalents of amine per gram of the amino-functional silicone. It can be determined by titration and also expressed in mg KOH / g.
  • Cosmetic or dermatological preparations preferred according to the invention are characterized in that, based on their weight, they contain 0.01 to 10% by weight, preferably 0.1 to 8% by weight, particularly preferably 0.25 to 7.5% by weight and in particular from 0.5 to 5% by weight of amino-functional silicone (s).
  • the compositions of the invention may contain at least one polyammonium-polysiloxane compound.
  • the polyammonium-polysiloxane compounds may be obtained for example under the trade name Baysilone® ® GE Bayer Silicones.
  • Baysilone TP 3911, SME 253 and SFE 839 are preferred. Very particular preference is given to the use of Baysilone TP 3911 as the active component of the compositions according to the invention.
  • the polyammonium-polysiloxane compounds are present in the compositions according to the invention in an amount of from 0.01 to 10% by weight, preferably from 0.01 to 7.5, particularly preferably from 0.01 to 5.0% by weight, very particularly preferably from 0 , 05 to 2.5 wt.% Each used in relation to the total composition.
  • cyclic dimethicones designated as cyclomethicones according to INCI are also preferably used according to the invention.
  • cosmetic or dermatological preparations according to the invention are preferred which contain at least one silicone of the formula (Si-4)
  • x is a number from 3 to 200, preferably from 3 to 10, more preferably from 3 to 7 and in particular 3, 4, 5 or 6 stands.
  • the silicones described above have a backbone composed of -Si-O-Si units. Of course, these Si-O-Si units may also be interrupted by carbon chains. Appropriate molecules are accessible by chain extension reactions and are preferably used in the form of silicone-in-water emulsions. Agents which are likewise preferred according to the invention are characterized in that they contain at least one silicone of the formula (Si-5)
  • R 3 is Si [O-SiR 2] ⁇ - (CH 2 ) n - [O-SiR 2 ] y -O-SiR 3 (Si-5), in which R is identical or different radicals from the group -H, -Phenyl, -benzyl, -CH 2 -CH (CH 3 ) Ph, the d_ 2 o-alkyl radicals, preferably -CH 3 , -CH 2 CH 3 , -CH 2 CH 2 CH 3 , -CH (CH 3 ) 2 , -CH 2 CH 2 CH 2 H 3 , -CH 2 CH (CH 3 ) 2 , -CH (CH 3 ) CH 2 CH 3 , -C (CH 3 ) 3 , x and y are each a number of 0 to 200, preferably from 0 to 10, more preferably from 0 to 7 and especially 0, 1, 2, 3, 4, 5 or 6, and n is a number from 0 to 10, preferably from 1 to 8 and especially for
  • water-soluble silicones may be present in the compositions according to the invention.
  • these additional silicones are water-soluble.
  • hydrophilic silicones are, for example, from the compounds of the formulas
  • Silicone base are selected from the group of dimethicone copolyols which are preferably alkoxylated, in particular polyethoxylated or polypropoxylated.
  • Dimethicone copolyols according to the invention are preferably polyoxyalkylene-modified
  • Alkoxy group having 1 to 12 carbon atoms or a hydroxyl group the radicals R 'and R "are alkyl groups having 1 to 12 carbon atoms
  • x is an integer from 1 to 100, preferably from 20 to 30
  • y is a integer from 1 to 20, preferably from 2 to 10
  • a and b are integers from 0 to 50, preferably from 10 to 30.
  • dimethicone copolyols according to the invention are, for example, the products sold commercially under the trade name SILWET (Union Carbide Corporation) and DOW CORNING (Dow).
  • Dimethicone copolyols particularly preferred according to the invention are Dow Corning 190 and Dow Corning 193 (Dow).
  • the dimethicone copolyols are present in the compositions according to the invention in amounts of from 0.01 to 10% by weight, preferably from 0.01 to 8% by weight, more preferably from 0.1 to 7.5% by weight and in particular from 0.1 to 5% by weight. % of dimethicone copolyol based on the composition.
  • the dimethiconols according to the invention can be both linear and branched as well as cyclic or cyclic and branched.
  • Linear dimethiconols can be represented by the following structural formula (Si8 - I): (SiOHR 1 2 ) - O - (SiR 2 2 - O -) x - (SiOHR 1 2 ) (Si 8 - I)
  • Branched dimethiconols can be represented by the structural formula ( Si8 - II) are shown:
  • the radicals R 1 and R 2 are each independently hydrogen, a methyl radical, a C 2 to C 30 linear, saturated or unsaturated hydrocarbon radical, a phenyl radical and / or an aryl radical.
  • the groups represented by R 1 and R 2 include alkyl groups such as methyl, ethyl, propyl, isopropyl, butyl, isobutyl, pentyl, isopentyl, neopentyl, amyl, isoamyl, hexyl, isohexyl and the like; Alkenyl radicals such as vinyl, halovinyl, alkylvinyl, allyl, haloallyl, alkylallyl; Cycloalkyl radicals such as cyclobutyl, cyclopentyl, cyclohexyl and the like; Phenyl radicals, benzyl radicals, halohydrocarbon radicals such as 3-chloropropyl, 4-
  • R 1 examples include methylene, ethylene, propylene, hexamethylene, decamethylene, -CH 2 CH (CH 3 ) CH 2 -, phenylene, naphthylene, -CH 2 CH 2 SCH 2 CH 2 -, -CH 2 CH 2 OCH 2 - , -OCH 2 CH 2 -, -OCH 2 CH 2 CH 2 -, -CH 2 CH (CH 3 ) C (O) OCH 2 -, - (CH 2 ) 3 CC (O) OCH 2 CH 2 -, C 6 H 4 C 6 H 4 -, -C 6 H 4 CH 2 C 6 H 4 -; and - (CH 2 ) 3 C (O) SCH 2 CH 2 -.
  • R 1 and R 2 are methyl, phenyl and C 2 to C 22 alkyl radicals. Of the C2 to C22 alkyl radicals, lauryl, stearyl and behenyl radicals are particularly preferred.
  • the numbers x, y and z are integers and each run independently from 0 to 50,000.
  • the molecular weights of the dimethiconols are between 1,000 D and 10000000 D.
  • the viscosities are between 100 and 10,000,000 cPs measured at 25 0 C by means of a glass capillary viscometer according to Dow Corning Corporate Test Method CTM 0004 dated 20 July 1970. Preferred viscosities are from 1000 to 5,000,000 cPs, most preferred viscosities are between 10,000 and 3,000,000 cps. The most preferred range is between 50,000 and 2,000,000 cps.
  • Examples of such products include the following commercial products: Dow Coming 1-1254 Fluid, Dow Corning 2-9023 Fluid, Dow Corning 2-9026 Fluid, X-21-5619 (Shin- Etsu Chemical Co.), Abil OSW 5 (U.S. Dow Corning 1401 Fluid, Dow Coming 1403 Fluid, Dow Corning 1501 Fluid, Dow Corning 1784 HVF Emulsion, Dow Corning 9546 Silicone Elastomer Blend (all Dow Coming Corporation previously mentioned), Silsoft 148, Silsoft E-50, Silsoft E-623 (all aforementioned Crompton Corporation), SM555, SM2725, SM2765, SM2785 (all GE Silicones mentioned above), Wacker-Belsil CM 1000, Wacker-Belsil CM 3092, Wacker-Belsil CM 5040, Wacker-Belsil DM 3096, Wacker-Belsil DM 31 12 VP, Wacker
  • the dimethiconols (Si8) are present in the compositions of the invention in amounts of
  • 0.01 to 10 wt.% Preferably 0.01 to 8 wt.%, Particularly preferably 0.1 to 7.5 wt.% And in particular 0.1 to 5 wt.% Of dimethiconol based on the composition.
  • this mixture is in the inventive compositions in amounts of 0.01 to 10 wt.%, Preferably 0.01 to 8 wt.%, Particularly preferably 0.1 to 7.5 wt .% And in particular 0.1 to 5 wt.% At
  • Silicone mixture based on the composition included.
  • Ingredients b) from the different classes mentioned at least two different classes can be used in the compositions according to the invention.
  • Active substance combination (A) cosmetic oils Preferably, these oil bodies have a melting point of less than 50 0 C, more preferably less than 45 0 C, most preferably less than 40
  • the cosmetic oils are flowable at a temperature of less than 30 0 C.
  • these oils are defined and described in more detail.
  • natural and synthetic cosmetic oils include: vegetable oils.
  • vegetable oils examples include sunflower oil, olive oil, soybean oil, rapeseed oil, almond oil, jojoba oil, orange oil, wheat germ oil, peach kernel oil and the liquid portions of coconut oil.
  • triglyceride oils such as the liquid portions of beef tallow as well as synthetic triglyceride oils.
  • the compounds are available as commercial products 1, 3-di- (2-ethyl-hexyl) - cyclohexan (Cetiol ® S), and di-n-octyl ether (Cetiol ® OE) may be preferred.
  • Ester oils are to be understood as meaning the esters of C 6 - C 30 fatty acids with C 2 - C 30 fatty alcohols.
  • the monoesters of the fatty acids with alcohols having 2 to 24 carbon atoms are preferred.
  • fatty acid components used in the esters are caproic acid, caprylic acid, 2-ethylhexanoic acid, capric acid, lauric acid, isotridecanoic acid, myristic acid, palmitic acid, palmitoleic acid, stearic acid, isostearic acid, oleic acid, elaidic acid, Petroselinic acid, linoleic acid, linolenic acid, elaeostearic acid, arachidic acid, gadoleic acid, behenic acid and erucic acid and their technical mixtures.
  • fatty alcohol components in the ester oils are isopropyl alcohol, caproic alcohol, capryl alcohol, 2-ethylhexyl alcohol, capric alcohol, lauryl alcohol, isotridecyl alcohol, myristyl alcohol, cetyl alcohol, palmoleyl alcohol, stearyl alcohol, isostearyl alcohol, oleyl alcohol, elaidyl alcohol, petroselinyl alcohol, linolyl alcohol, linolenyl alcohol, elaeostearyl alcohol, arachyl alcohol, gadoleyl alcohol, Behenyl alcohol, erucyl alcohol and brassidyl alcohol and their technical mixtures.
  • isopropyl myristate IPM Rilanit ®
  • isononanoic acid C16-18 alkyl ester Cetiol ® SN
  • 2-ethylhexyl palmitate Cegesoft ® 24
  • stearic acid-2-ethylhexyl ester Cetiol ® 868
  • cetyl oleate glycerol tricaprylate, Kokosfettalkohol- caprate / caprylate (Cetiol ® LC)
  • n-butyl stearate oleyl erucate
  • isopropyl palmitate IPP Rilanit ®
  • oleyl Oleate Cetiol ®
  • hexyl laurate Cetiol ® A
  • di-n-butyl adipate Cetiol ® B
  • myrist IPM Rilanit ®
  • Dicarboxylic acid esters such as di-n-butyl adipate, di- (2-ethylhexyl) adipate, di- (2-ethylhexyl) succinate and di-isotridecyl acelate
  • diol esters such as ethylene glycol dioleate, ethylene glycol diisotridecanoate, propylene glycol di (2- ethylhexanoate), propylene glycol diisostearate,
  • Fatty acid partial glycerides ie monoglycerides, diglycerides and their technical mixtures. With the use of technical products production reasons may still contain small amounts of triglycerides.
  • the partial glycerides preferably follow the formula (D4-I),
  • R 3 in the R 1 , R 2 and R 3 is independently of one another hydrogen or a linear or branched, saturated and / or unsaturated acyl radical having 6 to 22, preferably 12 to 18, Carbon atoms are provided with the proviso that at least one of these groups is an acyl radical and at least one of these groups is hydrogen.
  • the sum (m + n + q) is 0 or numbers from 1 to 100, preferably 0 or 5 to 25.
  • R 1 is an acyl radical and R 2 and R 3 are hydrogen and the sum (m + n + q) is 0.
  • Typical examples are mono- and / or diglycerides based on caproic, caprylic, 2-ethylhexanoic, capric, lauric, isotridecanoic, myristic, palmitic, palmitic, stearic, isostearic, oleic, elaidic, petroselic, linoleic, linolenic , Elaeostearic acid, arachidic acid, gadoleic acid, behenic acid and erucic acid and their technical mixtures.
  • oleic acid monoglycerides are used.
  • Natural oils include, for example, amaranth seed oil, apricot kernel oil, argan oil, avocado oil, babassu oil, cottonseed oil, borage seed oil, camelina oil, thistle oil, peanut oil, pomegranate seed oil, grapefruit seed oil, hemp oil, hazelnut oil, elderflower seed oil, currant seed oil, jojoba oil, cocoa butter, linseed oil, macadamia nut oil, corn oil, almond oil, marula oil , Evening primrose oil, olive oil, palm oil, rapeseed oil, rice oil, sea buckthorn fruit oil, sea buckthorn seed oil, sesame oil, shea butter, soybean oil, sunflower oil, grapeseed oil, walnut oil or wild rose oil.
  • Preferred natural oils contain at least the fatty acids palmitic acid, stearic acid and linoleic acid.
  • Particularly preferred natural oils contain the fatty acids palmitic acid, stearic acid and linoleic acid in a total amount of at least 50% by weight of the fatty acids.
  • Very particularly preferred oils are furthermore distinguished by an additional content of squalene.
  • Highly preferred natural oils and their mixtures also have a content of linolenic acids.
  • the teaching of the invention also includes that at least two natural oils can be mixed together.
  • Preferred blends of the natural oils are amaranth seed oil with at least one sea buckthorn oil, shea butter amaranth seed oil, camellina oil amaranth seed oil, amaranth seed oil with olive oil, amaranth seed oil with macadamia nut oil, olive oil with at least one sea buckthorn oil, camelina olive oil, shea butter olive oil, macadamia nut oil and at least one sea buckthorn oil, macadamia nut oil shea butter.
  • Argan oil is one of the most preferred natural oils.
  • Another preferred natural oil is Amaranth seed oil.
  • a suitable oil according to the invention is available, for example, from the company Euro Ingredients under the trade name "Amaranth Seed OiI.”
  • Shea butter is another example of the natural oils Shea butter according to the invention is not used alone but solely in admixture with at least one further natural oil, so that the total content of the fatty acids palmitic acid, stearic acid and linoleic acid is at least 50% by weight.
  • the amount used of the natural and synthetic cosmetic oil bodies in the compositions used according to the invention is usually 0.1 to 30% by weight, based on the total composition, preferably 0.1 to 20% by weight, and in particular 0.1 to 15% by weight. -%.
  • a very particularly preferred embodiment contains in addition to the two ingredients a) and b) additionally at least one further cationic compound.
  • This cationic compound can be a cationic surfactant, a cationic polymer or at least one cationic surfactant and one cationic polymer.
  • Cationic in the sense of the invention in this embodiment is also to be understood as an amphoteric polymer. For the description and definition of both the other cationic surfactants and the cationic and / or amphoteric polymers will be discussed in the following description at a given place.
  • the agents contain at least one surface-active substance, with both anionic and zwitterionic, ampholytic, nonionic and cationic surface-active substances being suitable in principle.
  • the choice of surfactants depends on the nature of the agent.
  • at least one surfactant is selected from the group of anionic, zwitterionic or nonionic surface-active substances. It is preferred here that at least one anionic and at least one zwitterionic surface-active substance be selected.
  • These surface-active substances are particularly preferably selected from the group of particularly mild surface-active substances. In many cases, however, it has proved to be advantageous to select the surfactants from anionic, zwitterionic or nonionic surfactants.
  • the ratio between anionic and zwitterionic surface-active substances is between 10: 1 and 1: 5.
  • the ratio is particularly preferably 5: 1 to 1: 2.
  • cationic surfactants are preferably used as surface-active substances or nonionic surfactants selected. Again, a selection of the so-called mild surface-active substances is particularly preferred.
  • the surfactants essentially comprise two groups, the surfactants and the emulsifiers.
  • surfactants is understood to mean surface-active substances which form adsorption layers at the upper and boundary surfaces or which can aggregate in volume phases to give micelle colloids or lyotropic mesophases.
  • anionic surfactants in preparations according to the invention are all anionic surfactants suitable for use on the human body.
  • anionic surfactants are alkylbenzenesulfonates, alkanesulfonates, olefinsulfonates, alkyl ether sulfonates, glycerol ether sulfonates, ⁇ -methyl ester sulfonates, sulfo fatty acids, alkyl sulfates, fatty alcohol ether sulfates, glycerol ether sulfates, hydroxy mixed ether sulfates, monoglyceride (ether) sulfates, fatty acid amide (ether) sulfates, mono- and dialkyl sulfosuccinates, mono and dialkyl sulfosuccinamates, sulfotriglycerides, amide soaps, ether carboxylic acids and their salts, fatty
  • anionic surfactants contain polyglycol ether chains, these may have a conventional, but preferably a narrow homolog distribution.
  • particularly suitable anionic surfactants are, in each case in the form of the sodium, potassium and ammonium as well as the mono-, di- and trialkanolammonium salts having 2 to 4 C atoms in the alkanol group, linear and branched fatty acids having 8 to 30 C Atoms (soaps),
  • Sulfobernsteinklamono- and dialkyl esters having 8 to 24 carbon atoms in the alkyl group and sulfosuccinic monoalkylpolyoxyethylester having 8 to 24 carbon atoms in the alkyl group and 1 to 6 oxyethyl groups.
  • Particularly suitable sulfosuccinic acid esters are derived from fatty alcohol fractions having 12- 18 C atoms. linear alkanesulfonates having 8 to 24 carbon atoms, linear alpha-olefin sulfonates having 8 to 24 carbon atoms, alpha-sulfofatty acid methyl esters of fatty acids having 8 to 30 carbon atoms,
  • Alkyl sulfates and alkyl polyglycol ether sulfates of the formula RO (CH 2 -CH 2 O) x -OSO 3 H, in which R is a preferably linear alkyl group having 8 to 30 C atoms and x 0 or 1 to 12,
  • Hydroxysulfonates essentially corresponding to at least one of the following two formulas or mixtures thereof and salts thereof, CH 3 - (CH 2 ) y -CHOH- (CH 2 ) p - (CH-SO 3 M) - (CH 2 ) z -CH 2 -O- (C n H 2n O) x -H, and / or
  • Esters of tartaric acid and citric acid with alcohols which are adducts of about 2-15 molecules of ethylene oxide and / or propylene oxide with fatty alcohols having 8 to 22 C atoms,
  • R 1 (OCH 2 CH 2 ) n -O- (PO-OX) -OR 2 , in which R 1 is preferably an aliphatic hydrocarbon radical having 8 to 30 carbon atoms, R 2 is hydrogen, a radical (CH 2 CH 2 O ) n R 2 or X, n is from 1 to 10 and X is hydrogen, an alkali or alkaline earth metal or NR 3 R 4 R 5 R 6 , with R 3 to R 6 independently of one another represent hydrogen or a Ci to C 4 - hydrocarbon radical, is, sulfated fatty acid alkylene glycol esters of the formula RCO (AIkO) n SO 3 M in the RCO- for a linear or branched, aliphatic, saturated and / or unsaturated acyl radical having 6 to 22 carbon atoms, Alk for CH 2 CH 2 , CHCH 3 CH 2 and / or CH 2 CHCH 3 , n is from 0.5 to 5 and M is a metal such as alkali metal,
  • R 8 OC- (OCH 2 CH 2 ) x -OCH 2 - [CHO (CH 2 CH 2 O) y H] -CH 2 O (CH 2 CH 2 O) z -SO 3 X in which R 8 is CO for a linear or branched acyl radical having 6 to 22 carbon atoms, x, y and z in total for 0 or for numbers from 1 to 30, preferably 2 to 10, and X stands for an alkali or alkaline earth metal.
  • Typical examples of monoglyceride (ether) sulfates suitable for the purposes of the invention are the reaction products of lauric acid monoglyceride, coconut fatty acid monoglyceride, palmitic acid monoglyceride, stearic acid monoglyceride, oleic acid monoglyceride and tallow fatty acid monoglyceride and their ethylene oxide adducts with sulfur trioxide or chlorosulfonic acid in the form of their sodium salts.
  • R 8 CO is a linear acyl radical having 8 to 18 carbon atoms
  • Such products are available, for example, by the company Chem Y under the product Akypo ®.
  • Condensation products of a water-soluble salt of a water-soluble protein hydrolyzate-fatty acid condensation product are preferably present as alkali, ammonium, mono-, di- or trialkanolammonium salt.
  • Such products are available under the trademark Lamepon® ®, Maypon ®, Gluadin® ®, Hostapon® ® KCG or Amisoft ® commercially,
  • Preferred anionic surfactants are alkyl sulfates, alkyl polyglycol ether sulfates and ether carboxylic acids having 10 to 18 C atoms in the alkyl group and up to 12 glycol ether groups in the molecule, sulfosuccinic acid mono- and dialkyl esters having 8 to 18 C atoms in the alkyl group and sulfosuccinic acid monoalkylpolyoxyethylester with 8 to 18 carbon atoms in the alkyl group and 1 to 6 oxyethyl groups, Monoglycerdisulfate, alkyl and Alkenyletherphosphate and Eiweissfettkladensate.
  • compositions according to the invention it is particularly advantageous if mild anionic surfactants are used as anionic surfactants.
  • mild anionic surfactants are used as anionic surfactants.
  • the effect of the composition of the invention is particularly mild and gentle especially with regard to the needs of damaged hair.
  • Sulfobernsteinklamono- and dialkyl esters having 8 to 24 carbon atoms in the alkyl group and sulfosuccinic monoalkylpolyoxyethylester having 8 to 24 carbon atoms in the alkyl group and 1 to 6 oxyethyl groups.
  • Alkylpolyglykolethersulfate of the formula RO (CH 2 -CH 2 O) x -OSO 3 H, in which R is a preferably linear alkyl group having 8 to 30 carbon atoms and x 0 or 1 to 12,
  • Esters of tartaric acid and citric acid with alcohols which are adducts of about 2-15 molecules of ethylene oxide and / or propylene oxide with fatty alcohols having 8 to 22 C atoms,
  • mild anionic surfactants contain polyglycol ether chains, it is particularly preferred that they have a narrow homolog distribution. Particularly mild anionic surfactants with polyglycol ether groups without restricted homolog distribution can, for example, also be obtained if, on the one hand, the number of polyglycol ether groups is 4 to 12 and Zn or Mg ions are chosen as counterion.
  • the number of polyglycol ether groups is 4 to 12 and Zn or Mg ions are chosen as counterion.
  • Zn or Mg ions are chosen as counterion.
  • One example is the commercial product Texapon.RTM ® ASV.
  • mild and anionic surfactants mentioned heretofore and in the following can also be used in the form of their salts.
  • Particularly suitable mild anionic surfactants are in each case in the form of the lithium, magnesium, zinc, sodium, potassium and ammonium and the mono-, di- and Trialkanolammoniumsalze with 1 to 4 carbon atoms in the alkanol group.
  • the preferred ammonium ions are in addition to the ammonium ion as such monomethylammonium, dimethylammonium, trimethylammonium, monoethylammonium, diethylammonium, triethylammonium, monopropylammonium, dipropylammonium, tripropylammonium, monoisopropylammonium, diisopropylammonium, triisopropylammonium , Monobutylammonium, dibutylammonium, tributylammonium, monoisobutylammonium,
  • Diisobutylammonium triisobutylammonium, mono-t-butyl-ammonium, di-t-butyl-ammonium,
  • Tri-t-butylammonium ions and mixed ammonium ions such as, for example, methyl-ethylammonium, dimethyl-ethyl-ammonium, methyl-diethylammonium, methyl-propyl-ammonium,
  • teaching of the invention also includes the other not explicitly mentioned ammonium ions of these alkanolammonium salts.
  • compositions are used, alkyl and / or alkenyl oligoglycoside carboxylates, - sulfates, phosphates and / or -isethionate, which are derived from alkyl and / or alkenyl oligoglycosides of the general formula (Tnio-2), with the meaning
  • G glycoside unit derived from a sugar with 5 or 6 carbon atoms, p number from 1 to 10.
  • the mild anionic surfactant is selected from anionic alkyl polyglycosides, ether carboxylic acids, acyl isethionates, protein fatty acid condensates, taurates, sulfosuccinates, fatty acid amide ether sulfates, NRE fatty alcohol ether sulfates, acyl glutamates and acyl aspartates, and the like
  • the anionic alkyl polyglucosides such as
  • the mixing ratio of these surfactants is at least 10: 1 to 1:10.
  • Preferred is a mixing ratio of 5: 1 to 1: 5, more preferably from 2.5: 1 to 1: 2.5, and most preferably from about 1, 5: 1 to 1: 1.5.
  • At least one hydroxyl group is preferably in at least one of the radicals G by -OC-. 12 alkenyl-COOM, -OSO 3 M, -OP (O) (OM) 2 or -
  • an alkyl oligoglycoside carboxylate is particularly preferably used in which -O-C 1 .- ⁇ -
  • the radical is 0-CH 2 -COONa.
  • alkyl oligoglycoside carboxylate in which the alkyl radical is particularly preferably used
  • Laurylrest is. Especially preferred is a Laurylglucosidcarboxylat as a Plantapon ® LCG of
  • the glycoside units G are preferably derived from aldoses or ketoses.
  • alkylglycosides which are particularly preferably used as starting materials are therefore the
  • the index p in the general formula (I) indicates the degree of oligomerization, i.
  • the distribution of mono- and oligoglycosides and stands for a number between 1 and 10. While p in a given compound always has to be an integer and can take here especially the values p 1 to 6, the value p for a particular alkyl glycoside an analytic calculated arithmetical variable, which usually represents a fractional number.
  • p 1 to 6
  • Alkyl glycosides having a mean degree of oligomerization p of 1, 1 to 3.0 used. Particular preference is given to those alkyl glycosides whose degree of oligomerization is less than 1.5 and, in particular, lies between 1.1 and 1.4.
  • the alkyl radical R is derived from primary alcohols having 6 to 22, preferably 12 to 18
  • Typical examples are caproic alcohol, caprylic alcohol, capric alcohol,
  • Alcohols may contain and are based on natural fats and oils, for example
  • Palm oil, palm kernel oil, coconut oil or beef tallow are obtained.
  • Coconut oil is particularly preferred here.
  • the alkyl glycosides can also be of synthetic primary alcohols having 6 to 22 carbon atoms, in particular the so-called
  • Derive oxo alcohols which have a proportion of 5 to 40 wt .-% of branched isomers.
  • alkyl radicals are those having 8/10, 12/14, 8 to 16, 12 to 16 or 16 to 18
  • hydroxyl groups may also be etherified, for example.
  • the mild anionic surfactants used according to the invention and particularly preferably the
  • Alkyl and / or alkenyl oligoglycoside carboxylates, sulfates, phosphates and / or isoethionates are used in an amount of from 0.1 to 25% by weight, more preferably from 0.1 to 15% by weight and most preferably in used in an amount of 0.5 to 10.0 wt.%
  • the mild anionic surfactants used and particularly preferably the alkyl and / or alkenyl oligoglycoside carboxylates, sulfates, phosphates and / or isoethionates can completely or partially replace the customary anionic surfactants in these compositions.
  • the mild anionic surfactants according to the invention can be used as the sole anionic surfactant in the compositions, or mixtures of these mild anionic surfactants can be used with each other or with other conventional anionic surfactants.
  • These conventional anionic surfactants are explained in more detail later.
  • the mild anionic surfactants and other anionic surfactants may be present in a weight ratio ranging from 5: 0.05 to 1: 2, more preferably 3: 0.5 to 1: 2, especially 2.5: 0.5 to 1: 1 , 5, and most preferably 1, 5: 1 to 1: 1.5.
  • amphoteric and zwitterionic surfactants may be included in the compositions of the invention.
  • Zwitterionic surfactants are those surface-active compounds which carry in the molecule at least one quaternary ammonium group and at least one -COO () or -SO 3 () group.
  • Particularly suitable zwitterionic surfactants are the so-called betaines such as N-alkyl-N, N-dimethylammonium glycinates, for example cocoalkyl dimethylammonium glycinate, N-acylaminopropyl N, N-dimethylammonium glycinates, for example cocoacylaminopropyl-dimethylammonium glycinate, and 2-alkyl 3-carboxymethyl-3-hydroxyethyl-imidazolines having in each case 8 to 18 C atoms in the alkyl or acyl group, and the cocoacylaminoethylhydroxyethylcarboxymethylglycinate.
  • a preferred zwitterionic surfactant is the fatty acid amide derivative known by the INCI name Cocamidopropyl Betaine.
  • ampholytic surfactants are N-alkylglycines, N-alkylpropionic acids, N-alkylaminobutyric acids, N-alkyliminodipropionic acids, N-hydroxyethyl-N-alkylamidopropylglycines, N-alkyltaurines, N-alkylsarcosines, 2-alkylaminopropionic acids and alkylaminoacetic acids each having about 8 to 24 C Atoms in the alkyl group.
  • amphoteric or zwitterionic surfactants are alkylbetaines, alkylamidobetaines, amino-propionates, aminoglycinates, imidazolinium betaines and sulfobetaines.
  • ampholytic surfactants are N-cocoalkylaminopropionate, acylaminoethylaminopropionat the coconut and the C 2 - C 8 - sarcosine.
  • Nonionic surfactants contain as hydrophilic group e.g. a polyol group, a polyalkylene glycol ether group, or a combination of polyol and polyglycol ether groups.
  • hydrophilic group e.g. a polyol group, a polyalkylene glycol ether group, or a combination of polyol and polyglycol ether groups.
  • Such compounds are, for example
  • Polyol fatty acid esters such as the commercially available product ® Hydagen HSP (Cognis) or Sovermol ® - types (Cognis), alkoxylated triglycerides, alkoxylated fatty acid alkyl esters of formula (Tnio-1)
  • the alkyl and alkenyl oligoglycosides can be derived from aldoses or ketoses with 5 or 6 carbon atoms, preferably glucose.
  • the preferred alkyl and / or alkenyl oligoglycosides are thus alkyl and / or alkenyl oligoglucosides.
  • alkyl and / or alkenyl oligoglycosides whose degree of oligomerization is less than 1.7 and in particular between 1.2 and 1.4 are preferred.
  • the alkyl or alkenyl radical R 15 can also be derived from primary alcohols having 12 to 22, preferably 12 to 14 carbon atoms. Typical examples are lauryl alcohol, myristyl alcohol, cetyl alcohol, palmoleyl alcohol, stearyl alcohol, isostearyl alcohol, oleyl alcohol, elaidyl alcohol, petroselinyl alcohol, arachyl alcohol, gadoleyl alcohol, behenyl alcohol, erucyl alcohol, brassidyl alcohol and technical mixtures thereof. Alkyl oligoglucosides based on hydrogenated Ci 2 / i 4 coconut alcohol with a DP of 1 to 3
  • the preferred fatty acid N-alkylpolyhydroxyalkylamides are therefore fatty acid N-alkylglucamides as represented by the formula (Tnio-4):
  • the polyhydroxyalkylamides can also be derived from maltose and palatinose.
  • the sugar surfactants may preferably be present in the agents used according to the invention in amounts of from 0.1 to 20% by weight, based on the total agent. Amounts of 0.5-15% by weight are preferred, and most preferred are amounts of 0.5-7.5% by weight.
  • Other typical examples of nonionic surfactants are fatty acid amide polyglycol ethers, fatty amine polyglycol ethers, mixed ethers or mixed formalin, protein hydrolysates (especially wheat-based vegetable products) and polysorbates.
  • the alkylene oxide adducts to saturated linear fatty alcohols and fatty acids having in each case 2 to 30 moles of ethylene oxide per mole of fatty alcohol or fatty acid and the sugar surfactants have proven. Preparations having excellent properties are also obtained if they contain fatty acid esters of ethoxylated glycerol as nonionic surfactants.
  • the alkyl radical R contains 6 to 22 carbon atoms and may be both linear and branched. Preference is given to primary linear and methyl-branched in the 2-position aliphatic radicals.
  • Such alkyl radicals are, for example, 1-octyl, 1-decyl, 1-lauryl, 1-myristyl, 1-cetyl and 1-stearyl. Particularly preferred are 1-octyl, 1-decyl, 1-lauryl, 1-myristyl.
  • oxo-alcohols compounds with an odd number of carbon atoms in the alkyl chain predominate.
  • the compounds used as surfactant with alkyl groups may each be uniform substances. However, it is usually preferred to start from the production of these substances from native plant or animal raw materials, so as to obtain substance mixtures with different, depending on the particular raw material alkyl chain lengths.
  • compositions according to the invention having an additional content of from 0.1 to 20% by weight of nonionic surfactants having an HLB value of from 2 to 18.
  • nonionic surfactants having an HLB value of from 2 to 18.
  • Such products can be obtained by addition of ethylene oxide onto z.
  • the HLB value means the proportion of hydrophilic groups, eg. B. to glycol ether or polyol groups based on the total molecule.
  • the cationic surfactants (Tkat) are characterized as part of the active ingredient complex according to the invention in that they contribute, like the amphoteric and zwitterionic surfactants, to a significantly improved cosmetic appearance of the skin.
  • Cationic surfactants (Tkat) are generally derived from ammonium ions and have a structure (NR 1 R 2 R 3 R 4 ) * with a corresponding negatively charged counterion.
  • Further cationic surfactants are, for example, the esterquats or the imidazolium compounds.
  • Cationic surfactants (Tkat) of the quaternary ammonium compound type, the esterquats, the imidazolines and the amidoamines are particularly preferably used according to the invention.
  • Preferred quaternary ammonium compounds are ammonium halides, in particular chlorides and bromides, such as alkyltrimethylammonium chlorides, dialkyldimethylammonium chlorides and trialkyl methylammonium chlorides, eg.
  • alkyltrimethylammonium chlorides dialkyldimethylammonium chlorides and trialkyl methylammonium chlorides, eg.
  • cetyltrimethylammonium chloride, stearyltrimethylammonium chloride, distearyldimethylammonium chloride, lauryldimethylammonium chloride, lauryldimethylbenzylammonium chloride and tricetylmethylammonium chloride as well as the imidazolium compounds known under the INCI names Quaternium-27 and Quaternium-83.
  • the long alkyl chains of the above-mentioned surfactants preferably have 8 to 30 carbon atoms.
  • Typical examples of cationic surfactants are quaternary ammonium compounds and ester quats, especially quaternized fatty acid trialkanolamine ester salts.
  • the cationic imidazoline compounds, ie, compounds having a positively charged imidazoline ring are described by the following formula (Imi-I) shown.
  • the radicals R independently of one another each represent a saturated or unsaturated, linear or branched hydrocarbon radical having a chain length of 8 to 30 carbon atoms.
  • the preferred compounds for R each contain the same hydrocarbon radical.
  • the chain length of the radicals R is preferably 12 carbon atoms. Particular preference is given to compounds having a chain length of at least 16 carbon atoms and very particularly preferably having at least 20 carbon atoms. A most preferred compound has a chain length of 21 carbon atoms. A commercial product of this chain length is known, for example, under the name Quaternium-91. In the formula (Imi-I) is shown as a counterion methosulfate.
  • the counterions also include the halides, such as chloride, fluoride, bromide, or else phosphates.
  • Preferred ester quats are quaternized ester salts of fatty acids with triethanolamine, quaternized ester salts of fatty acids with diethanolalkylamines and quaternized ester salts of fatty acids with 1,2-dihydroxypropyldialkylamines.
  • Such products are marketed under the trade names Stepantex® ®, ® and Dehyquart® Armocare® ®. The products
  • Dehyquart ® F-75, Dehyquart ® C-4046, Dehyquart ® L80 and Dehyquart ® AU-35 are examples of such esterquats.
  • alkylamidoamines are obtained by amidation of natural or synthetic fatty acids and
  • Substance group provides the commercially available under the name Tegoamid ® S 18
  • the alkylamidoamines can be present both as such and by protonation in a correspondingly acidic solution in a quaternary compound in the
  • compositions according to the invention can also be used as a permanent quaternary compound in the compositions according to the invention.
  • Glucquat ® 100 is, according to INCI nomenclature a "lauryl methyl Gluceth-10
  • cationic surfactants of the present invention are also cationic
  • R here stands for a substituted or unsubstituted, branched or straight-chain alkyl or alkenyl radical having 11 to 35 carbon atoms in the chain
  • X is - O - or - NR 5 -
  • R 1 represents an alkylene group having 2 to 6 C atoms, which may be unsubstituted or substituted, in which case substitution with an -OH or -NH group is preferred in the case of a substitution,
  • R 2 , R 3 and R 4 each independently represent an alkyl or hydroxyalkyl group
  • radicals according to the invention are methyl, ethyl, propyl, isopropyl, butyl, isobutyl, tert-butyl,
  • Pentyl iso-pentyl, neo-pentyl, hexyl, iso-hexyl, hydroxyalkyl, dihydroxyalkyl, hydroxyethyl,
  • R 5 is hydrogen or a C1 to C6 straight or branched alkyl or
  • Alkenyl radical which may also be substituted by a hydroxy group, especially methyl
  • a " represents a halide such as fluoride, chloride or bromide, an alkyl sulfate such as a methosulfate or ethosulfate, a phosphate, a citrate, tartrate, maleate or fumarate
  • the teaching of the invention also includes the recognition that mixtures of at least two cationic surfactants can be used.
  • the cationic surfactants are preferably selected from at least two different structural classes of cationic surfactants.
  • the cationic surfactants are preferably contained in the agents used according to the invention in amounts of from 0.05 to 10% by weight, based on the total agent. Amounts of 0.1 to 5 wt .-% are particularly preferred.
  • the cationic surfactants include in particular alkylamidoamines, quaternized amidoamines, esterquats, cationic surfactants of the formula (Tkat-2) and cationic surfactants having at least one behenyl radical in the molecule.
  • Cationic, zwitterionic and / or amphoteric surfactants and mixtures thereof may be preferred according to the invention.
  • Anionic surfactants are used in particular when the compositions according to the invention are to be used as shower baths.
  • the surfactants (T) are used in amounts of 0.05-45% by weight, preferably 0.1-30% by weight and very particularly preferably 0.5-25% by weight, based on the total agent used according to the invention .
  • Emulsifiers which can be used according to the invention are, for example
  • Glucosides mixtures of alkyl (oligo) and fatty alcohols for example, the commercially available product ® Montanov 68,
  • Sterols examples of zoosterols are cholesterol and lanosterol. Examples of suitable phytosterols are ergosterol, stigmasterol and sitosterol.
  • Fatty acid esters of sugars and sugar alcohols such as sorbitol
  • Polyglycerols and polyglycerol derivatives such as polyglycerol poly-12-hydroxystearate (commercial product Dehymuls ® PGPH),
  • Linear and branched fatty acids with 8 to 30 C atoms and their Na, K, ammonium,
  • the agents according to the invention preferably contain the emulsifiers in amounts of 0.1-25% by weight, in particular 0.5-15% by weight, based on the total agent.
  • compositions according to the invention may preferably contain at least one nonionogenic emulsifier having an HLB value of 8 to 18.
  • Nonionic emulsifiers having an HLB value of 10 to 15 may be particularly preferred according to the invention.
  • the particularly mild surfactants and emulsifiers are preferably used in the compositions.
  • the alkyl sulfates and / or alkyl ether sulfates are used in amounts of less than 8% by weight, preferably less than 5% by weight and more preferably less than 2.5% by weight.
  • these compositions are free of alkyl sulfates and / or alkyl ether sulfates.
  • Free from in this context means that these ingredients are not used in any way, but it is possible that they may be introduced into the composition by other ingredients, such as the use of silicone emulsions, so "free from” preferably means smaller than 0.5% by weight, more preferably less than 0.1% by weight.
  • Very particularly cationic and / or amphoteric and / or zwitterionic polymers are used as further ingredients in the compositions according to the invention.
  • Cationic polymers are to be understood as meaning polymers which have a group in the main and / or side chain which may be “temporary” or “permanent” cationic.
  • "permanently cationic” refers to those polymers which have a cationic group, irrespective of the pH of the agent. These are usually polymers containing a quaternary nitrogen atom, for example in the form of an ammonium group. Preferred cationic groups are quaternary ammonium groups. In particular, those polymers in which the quaternary ammonium group is bonded via a C 1-4 hydrocarbon group to a polymer main chain constructed from acrylic acid, methacrylic acid or derivatives thereof have proven to be particularly suitable. Further cationic polymers according to the invention are the so-called “temporary cationic" polymers, which usually contain an amino group which, at certain pH values, is present as a quaternary ammonium group and thus cationically.
  • the cationic polymers according to the invention can be both firming and / or film-forming and / or antistatic and / or scavenging polymers as well as polymers having conditioning and / or thickening properties.
  • the suitable cationic polymers are preferably fixing and / or conditioning polymers.
  • polymers are meant both natural and synthetic polymers which may be cationic or amphoteric charged.
  • Both cationic and amphoteric or zwitterionic polymers can therefore be characterized by their cationic charge density.
  • the polymers of the invention are characterized by a charge density of at least 1 to 7 meq / g.
  • a charge density of at least 2 to 7 meq / g is preferred.
  • Particularly preferred is a charge density of at least equal to 3meq / g to 7 meq / g.
  • the molecular weight of the particular polymer is understood to mean the molecular weight which the manufacturer indicates in the corresponding data sheets by its method.
  • a molecular weight of at least 50,000 g / u has proven to be suitable according to the invention.
  • Polymers with a molecular weight of more than 100,000 g / u have proven to be particularly suitable.
  • Polymers with a molecular weight of more than 1,000,000 g / u are particularly suitable.
  • Suitable polymers have a value of greater than 100,000 for the product of cationic charge density and molecular weight. Particularly suitable are polymers which have a value of at least 200,000 for this product. Especially suitable are those polymers in which this product has a value greater than 250,000. Most suitable are those polymers in which this product has a value of at least 1,000,000. Preference is given to those polymers which have a sufficient solubility in water or alcohol in order to completely dissolve in the agent according to the invention.
  • the cationic polymers may be homopolymers or copolymers wherein the quaternary nitrogen groups are contained either in the polymer chain or preferably as a substituent on one or more of the monomers.
  • ammonium group-containing monomers may be copolymerized with non-cationic monomers.
  • Suitable cationic monomers are unsaturated, free-radically polymerizable compounds which carry at least one cationic group, in particular ammonium-substituted vinyl monomers, for example trialkylmethacryloxyalkylammonium, trialkylacryloxyalkylammonium,
  • Dialkyl diallyl ammonium and quaternary vinyl ammonium monomers with cyclic, cationic nitrogen-containing groups such as pyridinium, imidazolium or quaternary pyrrolidones, e.g. Alkylvinylimidazolium, Alkylvinylpyridinium, or Alyklvinylpyrrolidon salts.
  • the alkyl groups of these monomers are preferably lower alkyl groups such as C1 to C7 alkyl groups, more preferably C1 to C3 alkyl groups.
  • the ammonium group-containing monomers may be copolymerized with non-cationic monomers.
  • Suitable comonomers are, for example, acrylamide, methacrylamide; Alkyl and dialkylacrylamide, alkyl and dialkylmethacrylamide, alkylacrylate, alkylmethacrylate, vinylcaprolactone, vinylcaprolactam, vinylpyrrolidone, vinylester, e.g. Vinyl acetate, vinyl alcohol, propylene glycol or ethylene glycol, wherein the alkyl groups of these monomers are preferably C1 to C7 alkyl groups, more preferably C1 to C3 alkyl groups.
  • Suitable polymers having quaternary amine groups are, for example, the polymers described under the names Polyquaternium in the CTFA Cosmetic Ingredient Dictionary, such as methylvinylimidazolium chloride / inylpyrrolidone copolymer (Polyquaternium-16) or quaternized vinylpyrrolidone / dimethylaminoethyl methacrylate copolymer (Polyquaternium-11).
  • cationic polymers that can be included in the inventive composition, for example vinylpyrrolidone / dimethylaminoethyl copolymer available under the trade names Gafquat ® 755 N and Gafquat ® 734, United States is marketed by Gaf Co.
  • Gafquat ® 734 is particularly preferred suitable.
  • Other cationic polymers are, for example, Germany, marketed by the company BASF under the tradename Luviquat ® HM 550 copolymer of polyvinyl pyrrolidone and imidazolimine which ® by the company Calgon / USA under the trade name Merquat Plus 3300 sold terpolymer of dimethyldiallylammonium chloride, sodium acrylate and acrylamide and sold by the company ISP under the trade name Gafquat ® HS 100 vinylpyrrolidone / methacrylamidopropyltrimethylammonium chloride copolymer.
  • Homopolymers of the general formula (P1), - (CH 2 - [CR 1 COO- (CH 2 ) m N + R 2 R 3 R 4 ] ⁇ n X " (P1) in which R 1 -H or -CH 3 is R 2 , R 3 and R 4 are independently selected from C 1-4 -alkyl, -alkenyl or
  • n 1, 2, 3 or 4
  • X is a physiologically acceptable organic or inorganic anion, as well as copolymers consisting essentially of the monomer units listed in formula (monomer-3) and nonionic monomer units, are particularly preferred cationic polymers
  • R 1 is a methyl group
  • R 2 , R 3 and R 4 are methyl groups m has the value 2.
  • Suitable physiologically tolerated counterions X " are, for example, halide ions, sulfate ions, phosphate ions, methosulfate ions and organic ions such as lactate, citrate, tartrate and acetate ions.Holyidene ions, in particular chloride, are particularly suitable.
  • a particularly suitable homopolymer is the, if desired crosslinked, poly (methacryloyloxyethyltrimethylammonium chloride) with the INCI name Polyquaternium 37. such products are available, for example under the names Rheocare ® CTH (Cosmetic Rheologies) and Synthalen® ® CR (3V Sigma) in trade.
  • the crosslinking can, if desired, with the help of olefinically polyunsaturated compounds, for example Divinylbenzene, tetraallyloxyethane, methylenebisacrylamide, diallyl ether, polyallylpolyglyceryl ethers, or allyl ethers of sugars or sugar derivatives such as erythritol, pentaerythritol, arabitol, mannitol, sorbitol, sucrose or glucose are methylene bisacrylamide is a preferred crosslinking site ns.
  • olefinically polyunsaturated compounds for example Divinylbenzene, tetraallyloxyethane, methylenebisacrylamide, diallyl ether, polyallylpolyglyceryl ethers, or allyl ethers of sugars or sugar derivatives such as erythritol, pentaerythritol, arabitol, mannitol,
  • the homopolymer is preferably used in the form of a nonaqueous polymer dispersion which should not have a polymer content of less than 30% by weight.
  • Such polymer dispersions are (under the names Salcare ® SC 95 about 50% polymer content, additional components: mineral oil (INCI name: Mineral Oil) and tridecyl-polyoxypropylene-polyoxyethylene-ether (INCI name: PPG-1 trideceth-6) ) and Salcare ® SC 96 (about 50% polymer content, additional components: mixture of diesters of propylene glycol with a mixture of caprylic and capric acid (INCI name: propylene glycol Dicaprylate / Dicaprate) and tridecyl polyoxypropylene-polyoxyethylene-ether (INCI Designation: PPG-1-trideceth-6)) are commercially available.
  • Copolymers contain monomer units having the formula (Pmonomer-3) as a non-ionic monomer, preferably acrylamide, methacrylamide, acrylic acid and methacrylic acid alkyl esters CI_ 4-C- ⁇ - 4 -alkyl.
  • acrylamide is particularly preferred.
  • copolymers can also be used as in the case of the homopolymers above described, be networked.
  • a preferred copolymer according to the invention is the crosslinked one
  • Acrylamide-methacryloyloxyethyltrimethylammonium chloride copolymer Such copolymers in which the monomers are present in a weight ratio of about 20:80, are commercially available as approximately 50% non-aqueous polymer dispersion 92 under the name Salcare ® SC.
  • Suitable cationic polymers derived from natural polymers are cationic ones
  • Cationic polysaccharides have the general formula (P-3) GOB-N + R a R b R c X
  • G is an anhydroglucose residue, for example starch or cellulose anhydroglucose
  • B is a divalent linking group, for example alkylene, oxyalkylene, polyoxyalkylene or
  • R a , R b and R c are independently alkyl, aryl, alkylaryl, arylalkyl, alkoxyalkyl or
  • Alkoxyaryl each having up to 18 carbon atoms, wherein the total number of carbon atoms in R a , R b and R c is preferably not more than 20;
  • X ' is a common counter anion and is preferably chloride.
  • a cationic cellulose is sold under the name Polymer JR 400 from Amerchol ® and has the INCI designation Polyquaternium-10 degrees.
  • Another cationic cellulose carries the
  • Suitable cationic guar derivatives are marketed under the trade name Jaguar ® and have the INCI name guar hydroxypropyltrimonium chloride. Furthermore, particularly suitable cationic guar derivatives are also available from the company Hercules under the name
  • N-Hance ® on the market.
  • Further cationic guar derivatives are available from Cognis under the
  • Another particularly suitable cationic natural polymer is hydrocolloids of
  • chitosans Type of chitosans.
  • the chitosans to be used according to the invention are completely or partially deacetylated chitins.
  • a suitable chitosan is sold, for example, by Kyowa Oil & Fat, Japan under the trade name Flonac ®. It has a
  • chitosan salt is Chitosoniumpyrrolidoncarboxylat, which, for example, under the
  • Chitosan has a molecular weight of about 200,000 to 300,000 g / mol and is deacetylated to 70 to 85%.
  • As chitosan derivatives are quaternized, alkylated or hydroxyalkylated
  • More preferred cationic polymers include cationic alkyl polyglycosides, cationized honey, for example the commercial product Honeyquat 50 ®, polymeric dimethyldiallylammonium salts and their copolymers with esters and amides of acrylic acid and methacrylic acid.
  • cationic polymers include cationic alkyl polyglycosides, cationized honey, for example the commercial product Honeyquat 50 ®, polymeric dimethyldiallylammonium salts and their copolymers with esters and amides of acrylic acid and methacrylic acid.
  • Merquat ® 100 Poly (dimethyldiallylammonium chloride)
  • Merquat ® 550 dimethyldiallylammonium chloride-acrylamide copolymer
  • Such compounds are sold under the names Gafquat ® 734 and Gafquat ® 755 commercially,
  • Vinylpyrrolidone-vinyl imidazolium copolymers such as those offered under the names Luviquat ® FC 370, FC 550, FC 905 and HM 552, quaternized polyvinyl alcohol, as well as by the names of Polyquaternium 2, Polyquaternium 17, Polyquaternium 18 and Polyquaternium 27, having quaternary Nitrogen atoms in the polymer backbone,
  • Vinylpyrrolidone-vinylcaprolactam-acrylate terpolymers such as those offered with acrylic acid esters and acrylamides as the third monomer building commercially, for example, under the name Aquaflex ® SF 40.
  • Can be used as cationic polymers are sold under the names Polyquaternium-24 (commercial product z. B. Quatrisoft ® LM 200), known polymers.
  • Gaffix ® VC 713 manufactured by ISP:
  • the copolymers of vinylpyrrolidone such as the commercial products Copolymer 845 (ISP manufacturer) are Gafquat ® ASCP 1011, Gafquat ® HS 110, Luviquat ® 8155 and Luviquat ® MS 370 available are.
  • preferred cationic polymers are cationic cellulose derivatives and chitosan and its derivatives, in particular the commercial products Polymer ® JR 400, Hydagen ® HCMF and Kytamer ® PC, cationic guar derivatives, cationic honey derivatives, in particular the commercial product Honeyquat ® 50, cationic Alkylpolyglycodside according to DE-PS 44 13 686 and polymers of the type Polyquaternium-37.
  • cationized protein hydrolysates are to be counted among the cationic polymers, wherein the underlying protein hydrolyzate from the animal, for example from collagen, milk or keratin, from the plant, for example from wheat, corn, rice, potatoes, soy or almonds, marine life forms, for example from fish collagen or algae, or biotechnologically derived protein hydrolysates. Preference is given to those cationic protein hydrolyzates whose underlying protein content has a molecular weight of 100 to 25,000 daltons, preferably 250 to 5000 daltons.
  • cationic protein hydrolyzates are to be understood as meaning quaternized amino acids and mixtures thereof.
  • the cationic protein hydrolysates may also be further derivatized.
  • cationic protein hydrolysates and derivatives As typical examples of the cationic protein hydrolysates and derivatives according to the invention, those mentioned under the INCI names in the "International Cosmetic Ingredient Dictionary and Handbook", (seventh edition 1997, The Cosmetic, Toiletry and Fragrance Association 1 101 17 th Street, NW, Suite 300, Washington, DC 20036-4702) and commercially available products. Very particular preference is given to the cationic protein hydrolysates and derivatives based on plants.
  • the cationic polymers are preferably contained in the compositions according to the invention in amounts of from 0.05 to 10% by weight, based on the total agent. Amounts of 0.1 to 5 wt .-% are particularly preferred.
  • Amphoteric polymers like the cationic polymers, are most preferred polymers.
  • Amphoteric and / or cationic polymers preferred according to the invention are those polymers in which a cationic group is derived from at least one of the following monomers:
  • R 1 -CH CR 2 -CO-Z- (C n H 2n ) -N (+)
  • R 3 R 4 R 5 A () (monol) in the R 1 and R 2 independently represent hydrogen or a methyl group and R 3 , R 4 and R 5 independently represent alkyl groups having 1 to 4 carbon atoms, Z is an NH group or an oxygen atom, n is an integer from 2 to 5 and A () is the anion of an organic or inorganic acid, monomers having quaternary ammonium groups of the general formula (mono 2),
  • R 6 and R 7 are independently a (C 1 to C 4 ) alkyl group, in particular a methyl group and A "is the anion of an organic or inorganic acid.
  • the radicals R 3 , R 4 and R 5 in the formula (monol) are preferably methyl groups
  • Z is preferably an NH group
  • a ( ) preferably means a halide, methoxysulfate or ethoxysulfate ion. It is particularly preferred in this case to use acrylamidopropyltrimethylammonium chloride as the monomer (monol).
  • a ' preferably represents a halide ion, in particular chloride or bromide
  • Preferred amphoteric polymers according to the invention are polymers whose anionic group derives from at least one monomer of the formula (Mono3) monomeric carboxylic acids of the general formula (Mono3) or their salts with an organic or inorganic acid,
  • R 8 -CH CR 9 -COOH (mono 3) in which R 8 and R 9 are independently hydrogen or methyl groups.
  • monomer (Mono3) acrylic acid is used for the inventively preferred amphoteric polymers.
  • amphoteric polymers are copolymers of at least one monomer (monol) or (mono 2) with the monomer (mono 3), in particular copolymers of the monomers (mono 2) and (mono 3).
  • amphoteric polymers are copolymers of diallyl dimethyl ammonium chloride and acrylic acid. These copolymers are sold under the INCI name Polyquaternium-22, among others, with the trade name Merquat ® 280 (Nalco).
  • amphoteric polymers according to the invention may additionally comprise a monomer (mono 4) monomeric carboxamides of the general formula (mono 4),
  • R 10 -CH CR 11 -C-NH-R 12 (mono 4)
  • R 12 is a hydrogen atom or a (C 1 to C 8 ) alkyl group.
  • Comonomers are terpolymers of diallyldimethylammonium chloride, acrylamide and
  • Acrylic acid These copolymers are marketed ® under the INCI name Polyquaternium-39, among others, with the trade name Merquat Plus 3330 (Nalco).
  • amphoteric polymers are those polymers which are composed essentially
  • R 8 -CH CR 9 -COOH (mono 3) in which R 8 and R 9 are independently hydrogen or methyl groups.
  • monomers of the type (i) are used in which R 3 , R 4 and R 5 are methyl groups, Z is an NH group and A () is a halide, methoxysulfate or ethoxysulfate ion is; Acrylamidopropyl trimethyl ammonium chloride is a particularly preferred monomer (i).
  • acrylic acid is preferably used as the monomer (ii) for the polymers mentioned.
  • amphoteric polymers can generally be used both directly and in salt form, which is obtained by neutralization of the polymers, for example with an alkali metal hydroxide, according to the invention.
  • amphoteric polymers are preferably contained in the agents according to the invention in amounts of from 0.05 to 10% by weight, based on the total agent. Amounts of 0.1 to 5 wt .-% are particularly preferred.
  • the anionic polymers are anionic polymers which have carboxylate and / or sulfonate groups.
  • anionic monomers from which such polymers may consist are acrylic acid, methacrylic acid, crotonic acid, maleic anhydride and 2-acrylamido-2-methylpropanesulfonic acid.
  • the acidic groups may be wholly or partly present as sodium, potassium, ammonium, mono- or triethanolammonium salt.
  • Preferred monomers are 2-acrylamido-2-methylpropanesulfonic acid and acrylic acid.
  • Anionic polymers which contain 2-acrylamido-2-methylpropanesulfonic acid as the sole or co-monomer can be found to be particularly effective, it being possible for the sulfonic acid group to be wholly or partly present as sodium, potassium, ammonium, mono- or triethanolammonium salt ,
  • the homopolymer of 2-acrylamido-2-methylpropansulfon acid which is available for example under the name Rheothik ® 11-80 is commercially.
  • Preferred anionic copolymers are acrylic acid-acrylamide copolymers and in particular polyacrylamide copolymers with sulfonic acid-containing monomers.
  • a particularly preferred anionic copolymer consists of 70 to 55 mol% of acrylamide and 30 to 45 mol% of 2-acrylamido-2-methylpropanesulfonic acid, wherein the sulfonic acid group is wholly or partly in the form of sodium, potassium, ammonium, mono- or triethanolammonium Salt is present.
  • This copolymer may also be crosslinked, with crosslinking agents preferably polyolefinically unsaturated compounds such as tetraallyloxyethane, allylsucrose, allylpentaerythritol and methylenebisacrylamide are used.
  • crosslinking agents preferably polyolefinically unsaturated compounds such as tetraallyloxyethane, allylsucrose, allylpentaerythritol and methylenebisacrylamide are used.
  • crosslinking agents preferably polyolefinically unsaturated compounds such as tetraallyloxyethane, allylsucrose, allylpentaerythritol and methylenebisacrylamide are used.
  • Such a polymer is in the commercial product Sepigel ® 305 the company SEPPIC included.
  • Simulgel ® 600 as a compound with isohexadecane and polysorbate 80 Natriumacryloyldimethyltaurat copolymers have proven to be particularly effective according to the invention.
  • anionic homopolymers are uncrosslinked and crosslinked polyacrylic acids. Allyl ethers of pentaerythritol, sucrose and propylene may be preferred crosslinking agents. Such compounds are for example available under the trademark Carbopol ® commercially.
  • Copolymers of maleic anhydride and methyl vinyl ether, especially those with crosslinks, are also color-retaining polymers.
  • a 1, 9-decadiene crosslinked maleic acid-methyl vinyl ether copolymer is available under the name ® Stabileze QM.
  • the anionic polymers are preferably contained in the agents according to the invention in amounts of from 0.05 to 10% by weight, based on the total agent. Amounts of 0.1 to 5 wt .-% are particularly preferred.
  • polyurethanes consist of at least two different monomer types, a compound (monomer ⁇ having at least 2 active hydrogen atoms per molecule and a di- or polyisocyanate (monomer ⁇ ).
  • the compounds (monomer ⁇ ) may be, for example, diols, triols, diamines, triamines, polyetherols and polyesterols.
  • the compounds having more than 2 active hydrogen atoms are usually used only in small amounts in combination with a large excess of compounds having 2 active hydrogen atoms.
  • Examples of compounds (Monomer ⁇ ) are ethylene glycol, 1, 2 and 1, 3-propylene glycol, butylene glycols, di-, tri-, tetra- and poly-ethylene and -Propylenglykole, copolymers of lower alkylene oxides such as ethylene oxide, propylene oxide and butylene oxide, Ethylenediamine, propylenediamine, 1, 4-diaminobutane, hexamethylenediamine and ⁇ , ⁇ -diamines based on long-chain alkanes or polyalkylene oxides.
  • Polyurethanes in which the compounds (monomer ⁇ ) are diols, triols and polyetherols may be preferred according to the invention.
  • polyethylene glycols and polypropylene glycols having molecular weights between 200 and 3000, in particular between 1600 and 2500, have proven to be particularly suitable in individual cases.
  • Polyesterols are usually obtained by modifying the compound (Monomer ⁇ ) with dicarboxylic acids such as phthalic acid, isophthalic acid and adipic acid.
  • dicarboxylic acids such as phthalic acid, isophthalic acid and adipic acid.
  • the compounds (monomer)) are predominantly hexamethylene diisocyanate, 2,4- and 2,6-
  • Toluene diisocyanate 4,4'-methylene di (phenyl isocyanate) and in particular isophorone diisocyanate used.
  • agents according to the invention can be nonionic
  • Suitable nonionic polymers are, for example:
  • Vinylpyrrolidone / vinyl ester copolymers as sold, for example, under the trademark Luviskol ® (BASF).
  • Luviskol ® VA 64 and Luviskol ® VA 73, each vinylpyrrolidone / vinyl acetate copolymers, are also preferred nonionic polymers.
  • Cellulose ethers such as hydroxypropyl cellulose, hydroxyethyl cellulose and hydroxypropylcellulose Methylhy-, as sold for example under the trademark Culminal® ® and Benecel ® (AQUALON) and Natrosol ® grades (Hercules).
  • Starch and its derivatives in particular starch, such as Structure XL ® (National Starch), a multifunctional, salt-tolerant starch; shellac
  • the nonionic polymers are preferably contained in the compositions according to the invention in amounts of from 0.05 to 10% by weight, based on the total agent. Amounts of 0.1 to 5 wt .-% are particularly preferred.
  • the preparations used contain a plurality of, in particular two different polymers of the same charge and / or in each case an ionic and an amphoteric and / or nonionic polymer.
  • the polymers (P) are preferably present in the compositions used according to the invention in amounts of from 0.01 to 30% by weight, based on the total composition. Amounts of from 0.01 to 25, in particular from 0.01 to 15 wt .-%, are particularly preferred.
  • compositions according to the invention contain fatty substances (fat) as further active ingredient.
  • Fatty substances are to be understood as meaning fatty acids, fatty alcohols, natural and synthetic waxes, which can be in solid form as well as liquid in aqueous dispersion, and natural and synthetic cosmetic oil components.
  • fatty acids (Fatac) can be used linear and / or branched, saturated and / or unsaturated fatty acids having 6 to 30 carbon atoms. Preference is given to fatty acids with 10 - 22 carbon atoms.
  • isostearic as the commercial products Emersol ® 871 and Emersol ® 875
  • isopalmitic acids such as the commercial product Edenor ® IP 95, and all other products sold under the trade names Edenor ® (Cognis) fatty acids.
  • Further typical examples of such fatty acids are caproic, caprylic, 2-ethylhexanoic, capric, lauric, isotridecanoic, myristic, palmitic, palmitoleic, stearic, isostearic, oleic, elaidic, petroselic, linoleic, linoleic and erucic acid and their technical mixtures.
  • the amount used is 0.1 - 15 wt.%, Based on the total mean.
  • the amount is preferably 0.5-10% by weight, with amounts of 1-5% by weight being particularly advantageous.
  • Fatty alcohols may be used are saturated, mono- or polyunsaturated, branched or unbranched fatty alcohols with C 6 - C 30 -, preferably C 0 - C 22 - and particularly preferably C 2 - C 22 - carbon atoms.
  • Decanols, octanols, dodecadienol, decadienol, oleyl alcohol, eruca alcohol, ricinoleic alcohol, stearyl alcohol, isostearyl alcohol, cetyl alcohol, lauryl alcohol, myristyl alcohol, arachidyl alcohol, caprylic alcohol, capric alcohol, linoleyl alcohol, linolenyl alcohol and behenyl alcohol are, for example, decanol, octanolol, dodecadienol, decadienol , as well as their Guerbet alcohols, this list should have exemplary and non-limiting character.
  • the fatty alcohols are derived from preferably natural fatty acids, which can usually be based on recovery from the esters of fatty acids by reduction.
  • those fatty alcohol cuts which are produced by reduction of naturally occurring triglycerides such as beef tallow, palm oil, peanut oil, rapeseed oil, cottonseed oil, soybean oil, sunflower oil and linseed oil or fatty acid esters formed from their transesterification products with corresponding alcohols, and thus represent a mixture of different fatty alcohols.
  • Such substances are, for example, under the names Stenol ® such as Stenol ® 1618 or Lanette ® such as Lanette ® O or Lorol ®, for example, Lorol ® C8, Lorol C14 ®, Lorol C18 ®, ® Lorol C8-18, HD-Ocenol ®, Crodacol ® such as Crodacol ® CS, Novol ®, Eutanol ® G, Guerbitol ® 16, Guerbitol ® 18, Guerbitol ® 20, Isofol ® 12, Isofol ® 16, Isofol ® 24, Isofol ® 36, Isocarb ® 12, Isocarb ® 16 or acquire Isocarb® ® 24 for sale.
  • Stenol ® such as Stenol ® 1618 or Lanette ® such as Lanette ® O or Lorol ®
  • Lorol ® C8 Lorol C8-18
  • wool wax alcohols as are commercially available, for example under the names of Corona ®, White Swan ®, Coronet ® or Fluilan ® can be used according to the invention.
  • the fatty alcohols are used in amounts of from 0.1 to 30% by weight, based on the total preparation, preferably in amounts of from 0.1 to 20% by weight.
  • waxes can be used according to the invention are solid paraffins or isoparaffins, carnauba waxes, beeswaxes, candelilla waxes, ozokerites, ceresin, spermaceti, sunflower wax, fruit waxes such as apple wax or Citrus wax, Microwachse from PE or PP.
  • Such waxes are available, for example, from Kahl & Co., Trittau.
  • the amount used is 0.1-50% by weight, based on the total agent, preferably 0.1-20
  • the total amount of oil and fat components in the compositions according to the invention is usually 0.5-75% by weight, based on the total agent. Amounts of 0.5-35 wt .-% are preferred according to the invention.
  • compositions with the active substance complex according to the invention are protein hydrolysates and / or its derivatives (P).
  • protein hydrolyzates also means total hydrolyzates as well as individual amino acids and their derivatives as well as mixtures of different amino acids.
  • the molecular weight of the protein hydrolysates which can be used according to the invention is between 75, the molecular weight for glycine, and 200,000, preferably the molecular weight is 75 to
  • amino acids and their derivatives as protein hydrolysates according to the invention are: alanine, arginine, carnitine, creatine, cystathionine, cysteine, cystine, cystic acid,
  • Glycine histidine, homocysteine, homoserine, isoleucine, lanthionine, leucine, lysine, methionine,
  • Preferred amino acids are alanine, arginine, glycine, histidine, lanthionine, leucine, lysine, proline,
  • Histidine, lysine, serine and arginine are used. Most preferably, glycine, histidine, lysine and serine are used.
  • protein hydrolysates of both vegetable and animal or marine or synthetic origin can be used.
  • Animal protein hydrolysates are, for example, elastin, collagen, keratin, silk and milk protein protein hydrolysates, which may also be present in the form of salts.
  • Such products are, for example, under the trademarks Dehylan ® (Cognis), Promois ® (Interorgana)
  • Lexein ® Inolex
  • kerasol tm ® (Croda) sold.
  • Moringa oleifera Moringa pterygosperma
  • Protein for example, under the trade designation Puricare ® LS 9658 from Fa.
  • the protein extract from the seeds of the cosmetic compositions In the cosmetic compositions, the protein extract from the seeds of the cosmetic compositions, the protein extract from the seeds of the cosmetic compositions, the protein extract from the seeds of the cosmetic compositions, the protein extract from the seeds of the cosmetic compositions, the protein extract from the seeds of the cosmetic compositions, the protein extract from the seeds of the cosmetic compositions, the protein extract from the seeds of the cosmetic compositions, the protein extract from the seeds of the cosmetic compositions.
  • Soy, almonds, peas, potato and wheat protein hydrolysates are, for example, under the trademarks Gluadin ® (Cognis), diamine ® (Diamalt) ® (Inolex),
  • Crotein ® (Croda) available.
  • protein hydrolysates according to the invention are collagen hydrolyzates of fish or algae as well as protein hydrolysates of mussels or pearl hydrolyzates.
  • pearl extracts according to the invention are the commercial products Pearl Protein Extract
  • one of the pearl extracts is contained in an amount of at least 0.01 to 20% by weight.
  • amounts of the extract of 0.01 to 10 wt.%, Very particularly preferably amounts of 0.01 to 5 wt.% Based on the total cosmetic composition used.
  • Another very special protein hydrolyzate is extracted from the silk.
  • compositions used in the invention are the Seidenproteinhydroysate and / or their
  • Derivatives in amounts of 0.001 to 10 wt .-% based on the total agent Quantities of 0.005 to 5, in particular 0.01 to 3 wt .-%, are very particularly preferred.
  • protein hydrolysates are preferred as such, amino acid mixtures otherwise obtained may be used in their place, if appropriate. Also possible is the use of derivatives of protein hydrolysates, for example in the form of their
  • Fatty acid condensation products According to the invention it is also possible to use a mixture of several protein hydrolysates (P).
  • the protein hydrolysates (P) are in the compositions in concentrations of 0.001
  • % By weight up to 20% by weight, preferably from 0.05% by weight up to 15% by weight and very particularly preferably in amounts of from 0.05% by weight up to 5% by weight.
  • compositions according to the invention are from 0.05 to 10% by weight, based on the total composition, particularly preferably from 0.1 to 5, and in particular
  • vitamins are vitamins, provitamins or vitamin precursors.
  • Vitamins, pro-vitamins and vitamin precursors are particularly preferred, which are assigned to the groups A, B, C, E, F and H.
  • compositions according to the invention may additionally contain antimicrobial compounds.
  • Suitable antimicrobial compounds are, for. B. cationic surfactants such.
  • Good are also the antimicrobial biguanide compounds such.
  • the polyhexamethylene biguanide (Vantocil® IB, ICI) or the 1, 1 ' hexamethylene bis (4-chlorophenyl) biguanide (“chlorhexidine”) in the form of a water-soluble, compatible salt, e.g. In the form of the acetate or gluconate.
  • the antimicrobial 5-amino-hexahydropyrimidines z.
  • suitable antimicrobial agents are the non-cationic, phenolic, antimicrobial substances, in particular the halogenated phenols and diphenyl ethers. Particularly suitable antimicrobial compounds of this type are z. B. the
  • plant extracts (L) in the compositions according to the invention gives rise to further synergistic advantages. Usually these extracts are produced by extraction of the whole plant. However, in individual cases it may also be preferred to prepare the extracts exclusively from flowers and / or leaves or the roots of the plant.
  • Extracts of green tea, oak bark, stinging nettle, witch hazel, hops, chamomile, burdock root horsetail, lime blossom, almond, aloe vera, coconut, mango, apricot, lime, wheat, kiwi, melon, orange, grapefruit, sage, Rosemary, birch, Meadowfoam, Quendel, Yarrow, Valerian, Coffee, Cocoa, Moringa, Teaspoon, Meristem, Ginseng and Ginger root.
  • composition according to the invention are the extracts of green tea, almond, aloe vera, coconut, mango, apricot, lime, wheat, kiwi and melon.
  • compositions according to the invention it is furthermore advantageously possible to use an extract of a sweetgrass.
  • a sweetgrass examples of particularly important representatives are wheat, barley, rye, oats, spelled, corn, the various types of millet (European millet, crabgrass, millet), sugar cane, ryegrass, meadow foxtail, oat oat, ostrich grass, meadow fescue, whistleweed, bamboo, cotton grass, too Called cogon grass.
  • Most preferred is the extract from the roots of the flame grass, Imperata Cylindrica.
  • Such a raw material for example, under the trade name Moist 24 ® by the company. Sederma commercially available.
  • More resources are available, for example from the company Cognis under the trade name Primasponge ® commercially.
  • An inventive representative of these raw materials is for example Primaspong SS Ivory, which contains a bamboo extract according to the invention.
  • Another plant extract is the extract of Perikarp from Litchie chinensis.
  • compositions according to the invention contain purine and / or purine derivatives in narrower ranges.
  • inventively preferred cosmetic agents characterized in that they - based on their weight - 0.001 to 2.5 wt .-%, preferably 0.0025 to 1 wt .-%, particularly preferably 0.005 to 0.5 wt .-% and in particular from 0.01 to 0.1% by weight of purine (s) and / or purine derivative (s).
  • compositions are particularly preferred according to the invention.
  • Cosmetic agents preferred according to the invention are characterized in that they contain purine and / or purine derivative (s) of the formula (I)
  • radicals R 1 , R 2 and R 3 are independently selected from -H, - OH, -NH 2 , -SH and the radicals R 4 , R 5 and R 6 are independently selected from -H, -CH 3 and -CH 2 - CH 3 , where the following compounds are preferred:
  • Caffeine has proved particularly useful in hair cosmetic formulations, for example in shampoos, conditioners, hair lotions and / or lotions, preferably in amounts of from 0.005 to 0.25% by weight, more preferably from 0.01 to 0.1% by weight and in particular from 0.01 to 0.05 wt .-% (in each case based on the composition) can be used.
  • the agents according to the invention may contain at least one imidazole derivative.
  • the imidazole derivative is an imidazole according to one of the formulas Ect-I or Ect-II and / or a physiologically tolerable salt and / or an isomeric or stereomeric form of these compounds,
  • R 1 represents a hydrogen atom, a branched or unbranched C 1 -C 4 -alkyl radical or a C 2 -C 4 -hydroxyalkyl radical,
  • R 2 is a hydrogen atom, a grouping -COOR 5 or a grouping -
  • R 5 is a hydrogen atom, a C 1 - C 4 alkyl radical, a
  • R 3 and R 4 independently of one another represent a hydrogen atom, a C 1 - C 4 -
  • Alkyl radical or one of the two radicals represents a hydroxy group and n stands for an integer from 1 to 3.
  • Suitable physiologically acceptable salts of the general compounds of the formula (Ect-I) or (Ect-II) are, for example, the alkali metal, alkaline earth metal, ammonium, triethylamine or tris (2-hydroxyethyl) amine salts and those which are derived from the reaction of compounds of the formula (Ect-I) or (Ect-II) with inorganic and organic acids such as hydrochloric acid, phosphoric acid, sulfuric acid, branched or unbranched, substituted or unsubstituted (for example by one or more hydroxy groups) Ci - C 4 - Mono- or dicarboxylic acids, aromatic carboxylic acids and sulfonic acids such as acetic acid, citric acid, benzoic acid, maleic acid, fumaric acid, tartaric acid and p-toluenesulfonic acid.
  • inorganic and organic acids such as hydrochloric acid, phosphoric acid, sulfuric acid, branche
  • physiologically acceptable salts are the Na, K, Mg and Ca salts and ammonium salts of the compounds of the formula (Ect-I) or (Ect-II), and the salts which can be obtained by reacting compounds according to of the formula (Ect-I) or (Ect-II) with hydrochloric acid, acetic acid, citric acid and benzoic acid.
  • C 1 -C 4 -alkyl groups in the compounds according to the invention are methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl and tert-butyl.
  • Preferred alkyl groups are methyl and ethyl, methyl is a particularly preferred alkyl group.
  • Preferred C 2 -C 4 -hydroxyalkyl groups are the groups 2-hydroxyethyl, 3-hydroxypropyl or 4-hydroxybutyl; 2-hydroxyethyl is a particularly preferred hydroxyalkyl group.
  • Preferred compounds of the formula (Ect-I) or (Ect-II) are those in which the radical R 1 is a methyl group.
  • a very particularly preferred compound according to the general formula (Ect-I) or (Ect-II) is (S) -2-methyl-1, 4,5,6-tetrahydro-4-pyrimidinecarboxylic acid (ectoine) and the physiologically tolerated salts this connection.
  • a further very particularly preferred compound according to the general formula (Ect-I) or (Ect-II) is (S, S) -5-hydroxy-2-methyl-1, 4,5,6-tetrahydro-4-pyrimidinecarboxylic acid ( Hydroxyectoin) and the physiologically acceptable salts of this compound.
  • Another preferred active ingredient for additional use in the compositions according to the invention is taurine (2-aminoethanesulfonic acid) and / or a derivative of taurine.
  • Preferred taurine derivatives are N-monomethyltaurine and N, N-dimethyltaurine.
  • Further taurine derivatives for the purposes of the present invention are taurocholic acid and hypotaurine.
  • agents according to the invention which - based on their weight - 0.0001 to 10.0 wt .-%, preferably 0.0005 to 5.0 wt .-%, particularly preferably 0.001 to 2.0 wt .-% and In particular, 0.001 to 1, 0 wt .-% taurine and / or a derivative of taurine included.
  • the compositions according to the invention contain penetration aids and / or swelling agents (M). These excipients provide better penetration of active ingredients into the keratin fiber or help swell the keratin fiber.
  • urea and urea derivatives include, for example, urea and urea derivatives, guanidine and its derivatives, arginine and its derivatives, water glass, imidazole and its derivatives, histidine and its derivatives, benzyl alcohol, glycerol, glycol and glycol ethers, propylene glycol and propylene glycol, for example
  • a particularly preferred group of swelling agents may be hydantoins.
  • Compositions according to the invention contain hydantoin or at least one hydatoin derivative.
  • Hydantoin derivatives are particularly preferably used according to the invention, with 5-ureidohydantoin being particularly preferred. Regardless of whether hydantoin or hydantoin derivative (s) is / are used, amounts of from 0.02 to 2.5 wt .-% are very particularly preferred, from 0.05 to 1, 5 wt .-%, more preferably 0.075 to 1 wt .-% and in particular 0.1 to 0.25 wt .-% - each based on the total agent - most preferably.
  • cosmetic agents according to the invention which preferably contain 5-ureido-hydantoin (allantoin) are preferred.
  • biochinones Another group of very particular ingredients of the compositions of the invention are biochinones.
  • suitable biochinones are understood as meaning one or more ubiquinone (s) and / or plastoquinone (s).
  • the or the biochinone (s) is (are) in the inventive compositions - based on her
  • Another particularly preferred group of ingredients in the cosmetic compositions of the invention are betaines.
  • the compounds are to be understood, which at the same time both a group -NR 3 ⁇ +) as well as a group -CR 2 contain COO '' ', of similar structure sulfobetaines and compounds containing a moiety -NR 3 + and a
  • R 1 , R 2 , and R 3 here independently of one another represent:
  • R 4 , R 5 , R 6 , R 7 , R 8 and R 9 here independently of one another represent: hydrogen, • OR 10 ,
  • Betaines in the context of the invention are also to be understood as meaning those substances in which the mentioned characteristic groups are only present in the dissolved substance and within certain pH values. There are areas of the solution.
  • betains of the formula (AI) which are particularly suitable according to the invention are: carnitine, carnitine tartrate, carnitine magnesium citrate, acetyl carnitine, 3-O-lauroyl L-carnitine hydrochloride, SO-octanoyl L-carnitine hydrochloride, 3-0 Palmitoyl L-carnitine hydrochloride, taurine, tauryl lysylate, taurine tartrate, taurine ornithine, lysyl taurine and ornithyl taurine, betalain, 1, 1-dimethyl-proline, hercynin (N ⁇ , N ⁇ , N ⁇ -trimethyl-L-histidinium betaine), ergothionein ( Thionein, 2-mercapto-Na, Na, Na-trimethyl-L
  • compositions according to the invention may contain both a compound according to formula (Bet-I) and several, in particular two, compounds of the formula (Bet-I).
  • the agents according to the invention contain the betaines in amounts of from 0.001 to 20% by weight, based on the total agent. A content of 0.05 to 10 wt .-% is preferred.
  • the cosmetic compositions according to the invention may contain pharmacologically active substances to achieve certain effects, such as, for example, an anti-dandruff effect or effects against acne.
  • Examples of pharmacologically active substances are corticosteroids, ⁇ -blockers, estrogens, phytoestrogens, cyproterone acetate, vasodilating substances such as diazoxide, nifedipine and minoxidil, acetylsalicylic acid or salicylic acid.
  • compositions are perfumes.
  • perfume are perfume oils, fragrances and
  • the perfumes are generally in an amount of 0.05 to 5 wt .-%, preferably from 0.1 to
  • the perfumes can be diluted in liquid form, undiluted or with a solvent for
  • Perfumes can be added to the compositions.
  • Suitable solvents for this purpose are, for.
  • ethanol isopropanol
  • diethylene glycol monoethyl ether diethylene glycol monoethyl ether
  • glycerol diethylene glycol monoethyl ether
  • propylene glycol 1, 2
  • short-chain carboxylic acids can be used as an ingredient in the present invention.
  • Short-chain carboxylic acids and their derivatives in the context of the invention are understood to mean carboxylic acids which may be saturated or unsaturated and / or straight-chain or branched or cyclic and / or aromatic and / or heterocyclic and have a molecular weight of less than 750.
  • preference may be given to saturated or unsaturated straight-chain or branched carboxylic acids having a
  • Chain length of 1 to 16 C atoms in the chain most particularly those are those with a chain length of 1 to 12 C - atoms in the chain.
  • One use of the short-chain carboxylic acids is the adjustment of the pH of the cosmetic compositions according to the invention.
  • the inventive inventive concept is the adjustment of the pH of the cosmetic compositions according to the invention.
  • Salts are used according to the invention.
  • Examples of such salts are the alkali, alkaline earth,
  • Mono-, di- and trimethyl, -ethyl and -hydroxyethyl ammonium salts are to be understood.
  • alkaline-reacting amino acids such as arginine, lysine
  • Ornithine and histidine neutralized acids are used.
  • the sodium, potassium, ammonium and arginine salts are preferred salts.
  • hydroxycarboxylic acids examples include glycolic acid, glyceric acid,
  • Lactic acid Lactic acid, malic acid, tartaric acid or citric acid.
  • polyhydroxy compounds as active ingredient with the other components according to the invention may be particularly preferred.
  • Polyhydroxy compounds are understood as meaning organic compounds having at least two hydroxyl groups. In particular, for the purposes of the present invention, this is to be understood as meaning:
  • Polyols having at least two hydroxyl groups such as, for example, trimethylolpropane,
  • Carbohydrates, sugar alcohols and sugars and their salts in particular monosaccharides, disaccharides, trisaccharides and oligosaccharides, these also being protected in the form of aldoses, ketoses and / or lactoses and protected by customary and -OH and -NH protecting groups known in the literature, such as, for example, the triflate group, the trimethylsilyl group or acyl groups, and furthermore in the form of the methyl ethers and as phosphate esters,
  • monosaccharides having 3 to 8 C atoms such as, for example, trioses, tetroses, pentoses, hexoses, heptoses and octoses, these also being protected in the form of aldoses, ketoses and / or lactoses and by conventional and known in the literature -OH and -NH - protecting groups, such as the triflate group, the trimethylsilyl group or acyl groups, and furthermore in the form of the methyl ethers and as phosphate esters.
  • oligosaccharides having up to 50 monomer units, these also being protected in the form of aldoses, ketoses and / or lactoses and protected by customary and known in the literature -OH and -NH protecting groups, such as the triflate, trimethylsilyl or acyl groups and furthermore in the form of the methyl ethers and as phosphate esters.
  • agents according to the invention which, based on the weight of the composition, contain 0.01 to 5 wt.%, Preferably 0.05 to 4 wt.%, Particularly preferably 0.05 to 3.5% by weight and in particular 0.1 to 2.5% by weight of polyhydroxy compound (s).
  • Preservatives are the classes of substances listed in Appendix 6, Parts A and B of the European Cosmetics Regulation Use. Particularly preferred is mild preservation, ideally without the addition of typical preservatives.
  • aromatic alcohols such as, for example, phenoxyethanol, benzyl alcohol, phenethyl alcohol, phenoxyisopropanol,
  • Aldehydes such as formaldehyde solution and paraformaldehyde, glutaraldehyde
  • Parabens for example methylparaben, ethylparaben, propylparaben, butylparaben, isobutylparaben
  • 1, 2-alkanediols having 5 to 22 carbon atoms in the carbon chain such as 1, 2-pentanediol, 1, 2-hexanediol, 1, 2-heptanediol, 1, 2-decanediol, 1, 2-dodecanediol, 1, 2- hexadecanediol,
  • Formaldehyde-releasing compounds such as DMDM hydantoin, diazolidinyl urea
  • Halogenated compounds such as isothiazolinones such as methylchloroisothiazolinone / methylisothiazolinone, triclosan, triclocarban, iodopropynyl butylcarbamate, 5-bromo-5-nitro-1,3-dioxane, chlorhexidine digluconate and chlorhexidine acetate, 2-bromo-2-nitropropane-1,3-diol, methyldibromoglutaronitrile,
  • Inorganic compounds such as sulfites, boric acid and borates, bisulfites,
  • Cationic substances such as quaternium-15, benzalkonium chloride, benzethonium chloride, polyaminopropyl biguanide,
  • Organic acids and their physiologically acceptable salts such as citric acid, lactic acid, acetic acid, benzoic acid, sorbic acid, salicylic acid, dehydroacetic acid
  • Active ingredients with additional effects such as zinc pyrithione, piroctone olamine,
  • Antioxidants such as BHT (butylated hydroxytoluene), BHA (butylated hydroxyanisole), propyl gallate, t-butylhydroquinone,
  • the water activity in the compositions according to the invention can also be reduced to the extent that growth of microorganisms can no longer take place.
  • glycerol and sorbitol are used for this purpose.
  • the compositions according to the invention contribute to the preservation being possible in an outstanding manner with the mild preservative additives. But the complete abandonment of preservatives is possible and preferred according to the invention.
  • the amounts of preservative are from 0 to 5 wt.%, Preferably from 0 to 2 wt.%, Particularly preferably from 0 to 1 wt.% And most preferably from 0 to 0.8 wt.% Based on the total amount of the composition ,
  • compositions of the invention are Deowirkstoffe.
  • Deodorants can not only be used in deodorants to prevent underarm sweating. They can also be used in skin care products to influence sweat on other skin areas. This includes, for example, the scalp.
  • the inventive compositions significantly increase analytically detectable the deposition of deodorant substances on the skin and hair. In the panel test, this is also noticeable through a significantly prolonged effect.
  • Deowirkstoffe esterase inhibitors can be added. These are preferably trialkyl citrates such as trimethyl citrate, tripropyl citrate, triisopropyl citrate, tributyl citrate and in particular triethyl citrate (Hydagen® CAT, COGNIS).
  • esterase inhibitors are dicarboxylic acids and their esters, for example glutaric acid, glutaric acid monoethyl ester, glutaric acid diethyl ester, adipic acid, adipic acid monoethyl ester, diethyl adipate, malonic acid and diethyl malonate, hydroxycarboxylic acids and their esters, for example citric acid, malic acid, tartaric acid or diethyl tartrate.
  • Antibacterial agents that affect the bacterial flora may also be included. Examples of these are chitosan, phenoxyethanol and chlorhexidine gluconate.
  • 5-Chloro-2- (2,4-dichlorophenoxy) phenol which is marketed under the trade name Irgasan® by Ciba-Geigy, Basel / CH, has also proved to be particularly effective. It may be preferred according to the invention to use the agent according to the invention in the context of a color change of the hair. In particular, the oxidative color change is preferred because the care effect of the compositions of the invention is excellent even in the presence of an oxidizing agent. Preferred agents according to the invention therefore contain at least one oxidizing agent.
  • the oxidizing agents according to the invention are different from atmospheric oxygen and have such an oxidation potential that makes it possible to link disulphide bridges within or between the proteins of the hair keratin, oxidatively lighten the natural color pigment melanin and / or to oxidize a developer-type oxidation dye precursor.
  • the oxidizing agent is preferably hydrogen peroxide and / or at least one addition product thereof, in particular inorganic or organic compounds, such as, for example, sodium perborate, sodium percarbonate, magnesium percarbonate, Sodium percarbamide, polyvinylpyrrolidone n H 2 O 2 (n is a positive integer greater than 0),
  • the oxidizing agent is preferably contained in an amount of from 1.0 to 10% by weight, in particular from 3.0 to 10.0% by weight, in each case based on the weight of the ready-to-use agent, in the oxidative cosmetic agent.
  • the cosmetic agents additionally preferably contain at least one color-modifying component. It is u.a. Improves the authenticity of the color obtained against environmental influences.
  • the color-changing component is again preferably selected
  • the agents according to the invention should additionally contain at least one UV light protection filter.
  • UV light protection filters are meant organic substances capable of absorbing ultraviolet rays and absorbing the absorbed energy in the form of longer wavelength radiation, e.g. Heat again.
  • UVB filters can be oil-soluble or water-soluble. As oil-soluble substances are e.g. to call:
  • 4-aminobenzoic acid derivatives preferably 2-ethylhexyl 4- (dimethylamino) benzoate, 2-octyl 4- (dimethylamino) benzoate and A-
  • esters of cinnamic acid preferably 2-ethylhexyl 4-methoxycinnamate, A-
  • Esters of salicylic acid preferably 2-ethylhexyl salicylate, 4-isopropylbenzyl salicylate, homomenthyl salicylate;
  • Esters of benzalmalonic acid preferably di-2-ethylhexyl 4-methoxybenzmalonate; Triazine derivatives such as 2,4,6-trianilino (p-carbo-2'-ethyl-1'-hexyloxy) -1, 3,5-triazine and octyltriazone.
  • Propane-1,3-diones e.g. 1- (4-tert-butylphenyl) -3- (4'-methoxyphenyl) propane-1,3-dione;
  • Suitable water-soluble substances are:
  • Sulfonic acid derivatives of benzophenones preferably 2-hydroxy-4-methoxybenzophenone-5-sulfonic acid and its salts;
  • Sulfonic acid derivatives of the 3-benzylidene camphor e.g. 4- (2-oxo-3-bornylidenemethyl) benzenesulfonic acid and 2-methyl-5- (2-oxo-3-bomylidene) -sulfonic acid and its salts.
  • UV-A filter in particular derivatives of benzoylmethane come into question, such as 1- (4'-tert-butylphenyl) -3- (4'-methoxyphenyl) propane-1, 3-dione or 1-phenyl-3 (4'-isopropylphenyl) -propane-1,3-dione.
  • the UV-A and UV-B filters can also be used in mixtures.
  • insoluble pigments are also suitable for this purpose, namely finely dispersed metal oxides or salts, for example titanium dioxide, zinc oxide, iron oxide, aluminum oxide, cerium oxide, zirconium oxide, silicates (talc), barium sulfate and zinc stearate.
  • the particles should have an average diameter of less than 100 nm, preferably between 5 and 50 nm and in particular between 15 and 30 nm. They may have a spherical shape, but it is also possible to use those particles which have an ellipsoidal or otherwise deviating shape from the spherical shape.
  • secondary light stabilizers of the antioxidant type which interrupt the photochemical reaction chain which is triggered when UV radiation penetrates into the skin. Typical examples are superoxide dismutase, tocopherols (vitamin E) and ascorbic acid (vitamin C).
  • the cosmetic agents may contain other active ingredients, auxiliaries and additives, such as
  • Anti-dandruff agents such as Piroctone Olamine, Zinc Omadine and Climbazole,
  • Opacifiers such as latex, styrene / PVP and styrene / acrylamide copolymers
  • Pearlescing agents such as ethylene glycol mono- and distearate and PEG-3-distearate,
  • Propellants such as propane-butane mixtures, N 2 O, dimethyl ether, CO 2 and air,
  • a second subject of the invention is a method for hair treatment, in which a cosmetic composition according to claim 1 is applied to the hair and is rinsed by the hair after a contact time.
  • the exposure time preferably a few seconds to 100 minutes, more preferably 1 to 50 minutes and most preferably 1 to 30 minutes.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)

Abstract

L'invention concerne des préparations cosmétiques, notamment des conditionneurs capillaires, qui contiennent au moins un composé béhényle cationique et au moins un polymère silicone et/ou au moins une huile cosmétique. Le rapport en poids du composé béhényle cationique aux silicones et/ou aux huiles cosmétiques est compris entre 20:1 à 1:20.
PCT/EP2008/066424 2007-12-13 2008-11-28 Conditionneurs capillaires contenant des composés béhényle cationiques et des silicones sélectionnées et/ou des huiles cosmétiques WO2009074465A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE200710060530 DE102007060530A1 (de) 2007-12-13 2007-12-13 Haarkonditionierende Mittel mit kationischen Behenylverbindungen und ausgewählten Siliconen und/oder kosmetischen Ölen
DE102007060530.9 2007-12-13

Publications (2)

Publication Number Publication Date
WO2009074465A2 true WO2009074465A2 (fr) 2009-06-18
WO2009074465A3 WO2009074465A3 (fr) 2010-07-01

Family

ID=40755925

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2008/066424 WO2009074465A2 (fr) 2007-12-13 2008-11-28 Conditionneurs capillaires contenant des composés béhényle cationiques et des silicones sélectionnées et/ou des huiles cosmétiques

Country Status (2)

Country Link
DE (1) DE102007060530A1 (fr)
WO (1) WO2009074465A2 (fr)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011074142A1 (fr) * 2009-12-18 2011-06-23 L'oreal Procédé de traitement de fibres de kératine
WO2011054612A3 (fr) * 2009-10-26 2012-06-28 Henkel Ag & Co. Kgaa Agent de conditionnement capillaire pulvérisable
WO2015024079A1 (fr) * 2013-08-20 2015-02-26 L'oreal Composition cosmétique comprenant des silicones aminés, des tensioactifs cationiques et des esters spécifiques et méthode de traitement cosmétique
WO2015090882A1 (fr) * 2013-12-19 2015-06-25 Henkel Ag & Co. Kgaa Procédé de coloration capillaire d'oxydation avec addition de substances de soins
CN105377222A (zh) * 2013-07-19 2016-03-02 莱雅公司 包含特殊的两性表面活性剂和特殊的增稠聚合物的染色组合物
ES2575655B1 (es) * 2014-12-29 2017-03-02 Laboratorios Viñas S.A. Composición farmacéutica, para uso tópico, de ácido salicílico micronizado a alta concentración y método y uso correspondientes
US20210275410A1 (en) * 2016-10-10 2021-09-09 The Procter & Gamble Company Personal care compositions substantially free of sulfated surfactants and containing a gel network
US11337906B2 (en) 2018-12-31 2022-05-24 L'oreal Hair care and conditioning compositions
US11766391B2 (en) * 2018-05-22 2023-09-26 HSP Technologies LLC Hair care compositions and methods of making and using same
US11896689B2 (en) 2019-06-28 2024-02-13 The Procter & Gamble Company Method of making a clear personal care comprising microcapsules
US12053130B2 (en) 2021-02-12 2024-08-06 The Procter & Gamble Company Container containing a shampoo composition with an aesthetic design formed by bubbles

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3008613B1 (fr) * 2013-07-19 2015-07-17 Oreal Composition de coloration comprenant un tensio actif amphotere particulier et un tensioactif amide oxyethylene
FR3008614B1 (fr) * 2013-07-19 2015-07-31 Oreal Composition de coloration comprenant un tensio actif amphotere particulier et un tensioactif sulfate
FR3008612B1 (fr) * 2013-07-19 2015-07-17 Oreal Composition de coloration comprenant un tensio actif amphotere particulier et un polymere epaississant particulier
ES2661646T3 (es) * 2013-07-19 2018-04-02 L'oreal Composición de tinte que comprende un tensioactivo anfótero particular y un tensioactivo de amida oxietilenada o un tensioactivo de alcohol graso oxietilenado que comprende menos de 10 unidades de OE y mezcla de los mismos
FR3008616B1 (fr) * 2013-07-19 2015-08-21 Oreal Composition de coloration comprenant un tensioactif amphotere, procede de coloration et dispositif

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4673568A (en) * 1984-04-13 1987-06-16 L'oreal Hair-care composition and hair treatment process
US4950468A (en) * 1987-03-11 1990-08-21 Sunstar Kabushiki Kaisha Hair treating composition
WO1995024180A1 (fr) * 1994-03-09 1995-09-14 Unilever Plc Composition pour apres shampoing
WO1997007774A1 (fr) * 1995-08-23 1997-03-06 The Procter & Gamble Company Compose pour le traitement des cheveux
GB2316615A (en) * 1996-08-29 1998-03-04 R & C Products Pty Ltd Quaternary ammonium compounds and silicone polymers for hair conditioning
US5888488A (en) * 1991-04-01 1999-03-30 Shiseido Company Ltd. Hair cosmetic composition
EP0951898A1 (fr) * 1998-02-10 1999-10-27 Johnson & Johnson Consumer Companies, Inc. Compositions traitantes pour cheveux
US5989533A (en) * 1997-07-21 1999-11-23 Revlon Consumer Products Corporation Hair conditioning compositions containing alpha or beta hydroxy acid esters
US20020143063A1 (en) * 2001-01-29 2002-10-03 Alvarado Robert M. Hair conditioner composition that is non-irritating to the eyes
US20030147842A1 (en) * 2001-11-08 2003-08-07 Serge Restle Cosmetic compositions containing a particular aminosilicone and a conditioner, and uses thereof
DE102004037397A1 (de) * 2004-07-30 2006-03-23 Henkel Kgaa Haarkonditionierende Mittel mit Imidazolinen und aminofunktionellen Siliconen

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4237253A (en) 1977-04-21 1980-12-02 L'oreal Copolymers, their process of preparation, and cosmetic compounds containing them
US4122029A (en) 1977-07-27 1978-10-24 Dow Corning Corporation Emulsion compositions comprising a siloxane-oxyalkylene copolymer and an organic surfactant
US4265878A (en) 1979-06-07 1981-05-05 Dow Corning Corporation Antiperspirant stick compositions
JPS5699407A (en) 1980-01-09 1981-08-10 Kao Corp Hair rinse composition
EP0047714B1 (fr) 1980-09-05 1985-10-30 Ciba-Geigy Ag Mélanges de sels d'ammonium quaternaires, polymères, haut-moléculaires acryliques et de détergents, leur préparation et utilisation en formulations cosmétiques
JPS5813700A (ja) 1981-07-17 1983-01-26 花王株式会社 食器用洗浄剤組成物
US4421769A (en) 1981-09-29 1983-12-20 The Procter & Gamble Company Skin conditioning composition
DE3139438A1 (de) 1981-10-03 1983-04-21 Henkel KGaA, 4000 Düsseldorf Verwendung kolloidaler loesungen von seidenfibroin in haarkosmetischen mitteln und haarshampoo
EP0217274A3 (fr) 1985-09-30 1988-06-29 Kao Corporation Composition cosmétique pour les cheveux
DE3708451A1 (de) 1987-03-16 1988-10-06 Henkel Kgaa Zwitterionische polymere und deren verwendung in haarbehandlungsmitteln
DE3929973A1 (de) 1989-09-08 1991-03-14 Henkel Kgaa Haarpflegemittel
US5136093A (en) 1991-02-06 1992-08-04 Smith Ronald J Quaternized panthenol compounds and their use
DE4342560A1 (de) 1993-12-14 1995-06-22 Marbert Gmbh Ectoin und Ectoinderivate als Feuchtigkeitsspender in Kosmetikprodukten
DE4413686C2 (de) 1994-04-20 1996-10-24 Henkel Kgaa Kationische Zuckertenside, Verfahren zu ihrer Herstellung und deren Verwendung
CN100360054C (zh) 1995-03-06 2008-01-09 弗卢泰罗瑞士有限公司 从饮料或蔬菜制品中去除不需要的亲油性杂质和/或残留物的方法
GB9708182D0 (en) 1997-04-23 1997-06-11 Dow Corning Sa A method of making silicone in water emulsions
DE19738866A1 (de) 1997-09-05 1999-03-11 Henkel Kgaa Schaumarme Tensidmischungen mit Hydroxymischethern
DE19756454C1 (de) 1997-12-18 1999-06-17 Henkel Kgaa Verwendung von Glycerincarbonat
US5998537A (en) 1998-09-21 1999-12-07 Dow Corning Corporation Emulsions containing ultrahigh viscosity silicone polymers
FR2785183B1 (fr) 1998-11-04 2002-04-05 Oreal COMPOSITION TINCTORIALE CONTENANT UN COLORANT DIRECT CATIONIQUE ET UNE PYRAZOLO-[1,5-a]- PYRIMIDINE A TITRE DE BASE D'OXYDATION, ET PROCEDES DE TEINTURE
DE29908573U1 (de) 1999-05-14 1999-08-05 Wella Ag Haarfärbemittel
ES2227271T3 (es) 2000-07-27 2005-04-01 GE BAYER SILICONES GMBH & CO. KG Compuestos de poliamonio-polisiloxano, procedimiento para su produccion y su uso.

Patent Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4673568A (en) * 1984-04-13 1987-06-16 L'oreal Hair-care composition and hair treatment process
US4950468A (en) * 1987-03-11 1990-08-21 Sunstar Kabushiki Kaisha Hair treating composition
US5888488A (en) * 1991-04-01 1999-03-30 Shiseido Company Ltd. Hair cosmetic composition
WO1995024180A1 (fr) * 1994-03-09 1995-09-14 Unilever Plc Composition pour apres shampoing
WO1997007774A1 (fr) * 1995-08-23 1997-03-06 The Procter & Gamble Company Compose pour le traitement des cheveux
GB2316615A (en) * 1996-08-29 1998-03-04 R & C Products Pty Ltd Quaternary ammonium compounds and silicone polymers for hair conditioning
US5989533A (en) * 1997-07-21 1999-11-23 Revlon Consumer Products Corporation Hair conditioning compositions containing alpha or beta hydroxy acid esters
EP0951898A1 (fr) * 1998-02-10 1999-10-27 Johnson & Johnson Consumer Companies, Inc. Compositions traitantes pour cheveux
US20020143063A1 (en) * 2001-01-29 2002-10-03 Alvarado Robert M. Hair conditioner composition that is non-irritating to the eyes
US20030147842A1 (en) * 2001-11-08 2003-08-07 Serge Restle Cosmetic compositions containing a particular aminosilicone and a conditioner, and uses thereof
DE102004037397A1 (de) * 2004-07-30 2006-03-23 Henkel Kgaa Haarkonditionierende Mittel mit Imidazolinen und aminofunktionellen Siliconen

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011054612A3 (fr) * 2009-10-26 2012-06-28 Henkel Ag & Co. Kgaa Agent de conditionnement capillaire pulvérisable
WO2011074142A1 (fr) * 2009-12-18 2011-06-23 L'oreal Procédé de traitement de fibres de kératine
CN105377222A (zh) * 2013-07-19 2016-03-02 莱雅公司 包含特殊的两性表面活性剂和特殊的增稠聚合物的染色组合物
US10722449B2 (en) 2013-08-20 2020-07-28 L'oreal Cosmetic composition comprising amino silicones, cationic surfactants and specific esters and a process for a cosmetic treatment
WO2015024079A1 (fr) * 2013-08-20 2015-02-26 L'oreal Composition cosmétique comprenant des silicones aminés, des tensioactifs cationiques et des esters spécifiques et méthode de traitement cosmétique
CN105491992A (zh) * 2013-08-20 2016-04-13 欧莱雅 包含氨基有机硅、阳离子型表面活性剂和特定的酯的化妆品组合物，以及用于化妆品处理的方法
WO2015090882A1 (fr) * 2013-12-19 2015-06-25 Henkel Ag & Co. Kgaa Procédé de coloration capillaire d'oxydation avec addition de substances de soins
ES2575655B1 (es) * 2014-12-29 2017-03-02 Laboratorios Viñas S.A. Composición farmacéutica, para uso tópico, de ácido salicílico micronizado a alta concentración y método y uso correspondientes
US20210275410A1 (en) * 2016-10-10 2021-09-09 The Procter & Gamble Company Personal care compositions substantially free of sulfated surfactants and containing a gel network
US11766391B2 (en) * 2018-05-22 2023-09-26 HSP Technologies LLC Hair care compositions and methods of making and using same
US11337906B2 (en) 2018-12-31 2022-05-24 L'oreal Hair care and conditioning compositions
US11896689B2 (en) 2019-06-28 2024-02-13 The Procter & Gamble Company Method of making a clear personal care comprising microcapsules
US12053130B2 (en) 2021-02-12 2024-08-06 The Procter & Gamble Company Container containing a shampoo composition with an aesthetic design formed by bubbles

Also Published As

Publication number Publication date
DE102007060530A1 (de) 2009-09-17
WO2009074465A3 (fr) 2010-07-01

Similar Documents

Publication Publication Date Title
WO2009074465A2 (fr) Conditionneurs capillaires contenant des composés béhényle cationiques et des silicones sélectionnées et/ou des huiles cosmétiques
EP2931377B1 (fr) Produits de soins cheveux avec moyens antipelliculaires et silicones choisis contenant des structures de sucre
WO2009074463A2 (fr) Conditionneurs capillaires contenant des imidazolines et des silicones sélectionnées et/ou des huiles cosmétiques
DE102008060147A1 (de) Haarkonditionierende Mittel mit Imidazolinen und Esterölen
DE102015223028A1 (de) Haarkonditionierende Mittel
DE102011088558A1 (de) Haarbehandlungsmittel mit speziellen Polymeren
WO2010018047A2 (fr) Composition cosmétique contenant des huiles issues des fruits du sumac
DE102012203240A1 (de) Haarpflegemittel mit Antischuppenmitteln und ausgewählten Aminosilikonen
EP2931379A1 (fr) Agents de soins capillaires contenant des oligopeptides sélectionnés et/ou des hydrolysats protéiques cationiques sélectionnés et des silicones contenant des structures glucidiques
EP2931245A1 (fr) Agents de soins capillaires contenant des composes ammonium quarternaires selectionnes et des silicones contenant des structures glucidiques
WO2011009710A2 (fr) Produits de conditionnement capillaire contenant des imidazolines cationiques et des silicones cationiques sélectionnées
WO2009074464A2 (fr) Conditionneurs capillaires contenant des composés cationiques et des silicones sélectionnées et/ou des huiles cosmétiques
EP2830577A1 (fr) Produits de traitement capillaire contenant des amides d'acide gras et des corps gras sélectionnés
EP2830580A1 (fr) Produits de traitement capillaire contenant des amides d'acide gras et des silicones sélectionnés
DE102013212623A1 (de) Haarbehandlungsmittel enthaltend das Öl aus der Frucht des Feigenkaktus
WO2013087294A2 (fr) Produit de cure capillaire exempt de silicones arylées
DE102011088929A1 (de) Haarkur mit einem speziellen Emulgator und Proteinhydrolysaten
EP2571480A2 (fr) Produit de traitement capillaire contenant du polyquaternium-72
DE102013223918A1 (de) Haarbehanslungsmittel enthaltend Rosa Damascena Flower Oil
DE102013212618A1 (de) Haarbehandlungsmittel enthaltend Pequi-öl
WO2014090522A1 (fr) Agents de soins capillaires contenant des silicones contenant des structures glucidiques et d'autres silicones selectionnees
DE102013212621A1 (de) Haarbehandlungsmittel enthaltend Blütennektar
WO2014023533A2 (fr) Agents de soins capillaires contenant des agents anti-pelliculaires et des complexes choisis composés d'hydrolysats protéiques acides et d'amidoamines d'acides gras basiques
DE102013212619A1 (de) Haarbehandlungsmittel enhtaltend Pequi-öl
DE102013225374A1 (de) Pflegendes Reinigungsmittel und Verfahren zur Anwendung dieses Mittels

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08859532

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 08859532

Country of ref document: EP

Kind code of ref document: A2